Edgar Ribi Papers - Archives West

Edgar Ribi Papers, 1950-1986

Overview of the Collection

Creator: Ribi, Edgar, 1920-1986
Title: Edgar Ribi Papers
Dates: 1950-1986 (inclusive)
19501986
Quantity: 84.75 linear feet
Collection Number: Mss 197
Summary: This collection contains records generated and collected by Edgar Ribi over the course of his professional career as an academic, public employee, and for-profit researcher. The bulk of collection materials date from his years researching the fine structure of microbial cells, immunologically-active cell constituents, and vaccines for the National Institutes of Health (particularly at the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana).
Repository: University of Montana, Mansfield Library, Archives and Special Collections
Archives and Special Collections
Maureen and Mike Mansfield Library
University of Montana
32 Campus Dr. #9936
59812-9936
Missoula, MT
Telephone: 406-243-2053
library.archives@umontana.edu
Access Restrictions: Researchers must use collection in accordance with the policies of Archives and Special Collections, the Maureen and Mike Mansfield Library, and the University of Montana-Missoula.
Languages: English, German, Russian
Sponsor: Funding for encoding this finding aid was provided through a grant awarded by the National Endowment for the Humanities. Funding for preparing this finding aid was provided through a grant awarded by the National Historic Publications and Records Commission.

Biographical NoteReturn to Top

Edgar Ribi was born September 5, 1920, in Zurich, Switzerland. Ribi attended the Bern Institute of Technology from 1937 to 1940. He graduated with a diploma in Chemical Engineering. Ribi then attended the University of Bern and received Ph.D's in chemistry, physics, and mineralogy between 1940 and graduated magna cum laude in 1948. His thesis was on chemistry, morphology, and the crystal structure of inorganic colloids, examined by electron microscopy and electron and x-ray diffraction.

He married Karin Smith in 1951 and sired two children: Nils Andrew, and Hans Oliver. The Ribis came to the U.S. and became naturalized citizens.

From 1946 to 1948 Ribi was the instructor of analytical chemistry at Bern, Switzerland. He became the research associate to Professor T. Svedberg at the Institute of Physical Chemsitry in Upsala, Sweden. While there, Ribi also worked to perfect techniques on electron microscopy at the National Institutes of Health (NIH) Labs in Bethesda, Maryland. In 1951, he became the research associate to Professor A Tiselius, and worked on plant and animal fibrous tissues. From 1952 to 1958, he was a visiting scientist at National Institute of Allergy and Infectious Diseases (NIAID) for NIH. He reseached the fine structure of microbial cells and the immunologically-active cell constituents and vaccines. He also invented the Ribi Cell Fractionator, which broke cells open without harming them. From 1959 until his retirement in 1980 he was the head of the biophysics section of the NIAID Lab in Hamilton, Montana.

In 1981, he founded Ribi ImmunoChem Research, which became a leading biochemical research company, in Hamilton, Montana. The company worked on anti-cancer agents, anti-infectious agents, and super vaccines. Some of the products it developed were Ribigen (an anti-tumor agent used in cattle), Detox (a human anti-cancer agent), and Ovamid (an anti-tumor agent intended for treating ovarian and cervical cancers). The company received numerous patents for its products. Ribi ImmunoChem was acquired in 1999 by Corixa Corporation for $58.5 million, and continued operations in Hamilton.

Content DescriptionReturn to Top

This collection contains records generated and collected by Edgar Ribi over the course of his professional career as an academic, public employee, and for-profit researcher. The bulk of collection materials date from his years researching the fine structure of microbial cells, immunologically-active cell constituents, and vaccines for the National Institutes of Health (particularly at the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana). Collection materials include biographical materials on Edgar Ribi, correspondence directly related to research conducted at the Hamilton lab, research data files and reports, Ribi's written contributions to the field, records from the Ribi ImmunoChem company, and graphic representations of lab research.

These materials document a partial history of federal research at the laboratory in Hamilton and lend insights into the breadth of/developments within infectious disease and oncological research spanning the years during which these fields transformed from obscure specialities into major international health care commitments.

Use of the CollectionReturn to Top

Restrictions on Use

Researchers are responsible for using in accordance with 17 U.S.C. and any other applicable statutes. Copyright not transferred to the University of Montana.

Preferred Citation

[Name of document], Edgar Ribi Papers, Archives and Special Collections, The University of Montana-Missoula.

Administrative InformationReturn to Top

Arrangement

The collection is arranged in seven series:

Series I: Biographical, 1951-1980, 0.25 linear feet

Series II: General Correspondence, 1950-1986, 10.5 linear feet

Series III: Research, 1953-1980, 51 linear feet

Series IV: Speeches and Writings, 1954-1986, 13.0 linear feet

Series V: Ribi ImmunoChem, 1981-1986, 4.0 linear feet

Subseries 1: Company, 1981-1986, 3.0 linear feet

Subseries 2: Financial, 1981-1984, 1.0 linear feet

Series VI: Electron Micrographs, undated, 5.5 linear feet

Series VII: Chromatographs, undated, 0.5 linear feet

Series VIII: Photographs, 1928-1975, 9 images

Custodial History

The papers were in the possession of the Ribi family until donation to the Archives.

Acquisition Information

Gift of Nils and Hans Ribi, 1993.

Processing Note

The actions of the original processors are unknown. In 2004, the collection was divided into series and fully described. Materials related to Ribi ImmunoChem, which had been restricted by the donors until 2003, were added at this time; some publications not produced by or directly related to the company were discarded.

Detailed Description of the CollectionReturn to Top

Series I: Biographical, 1951-1980Return to Top

0.25 linear feet

This series contains formal biographical statements regarding Edgar Ribi, employment records from his years of service with the National Institutes of Health, and some internal correspondence regarding management decisions at the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana.

Container(s)	Description	Dates
Box/Folder
1/1	Employment data	1951
1/2	Employment data	1951
1/3	Employment data	1952
1/4	Employment data	1953
1/5	Employment data	1954-1958
1/6	Employment data	1960-1964
1/7	Employment data and bibliography	1968-1980

Series II: General Correspondence, 1950-1986 Return to Top

10.5 linear feet

This series contains extensive sequences of incoming and outgoing correspondence generated by, received by, or forwarded to Edgar Ribi during his years of service at the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana. In most instances correspondence sequences extend across several folders and contain submissions from a diverse collection of individuals representing National Institutes of Health administrators, staff from Federal regulatory agencies, academic and private researchers, and fellow Laboratory staff members.

Container(s)	Description	Dates
Box/Folder
2/1	American Lung Association	1969-1978
2/2	American Lung Association	1979-1986
2/3	Asselinau-Lederer-Jolles-Tanaka	1967-1969
2/4	Asselinau-Lederer-Jolles-Tanaka	1967
2/5	Azuma, Ichino	1978-1981
2/6	Azuma, Ichino	1976-1978
2/7	Azuma, Ichino	1972-1976
2/8	Azuma, Ichino	1970-1972
2/9	Azuma, P3 structure	undated
2/10	Azuma, P3 structure	undated
2/11	Azuma, Ichino	undated
2/12	Azuma, Ichino	undated
2/13	Azuma, Ichino	undated
3/1	"A" Miscellaneous	1951-1961
3/2	"A" Miscellaneous	1962-1967
3/3	"A" Miscellaneous	1967-1979
3/4	"A" Miscellaneous	1984
3/5	Ballou	1964-1975
3/6	Ballou	1965-1975
3/7	Barclay, William	1964-1966
3/8	Barclay, William	1967-1975
3/9	Barclay, William	undated
3/10	Brehmer, Werner	1966-1968
3/11	Brehmer, Werner	1968-1970
3/12	Brehmer, Werner	1970
3/13	Brehmer, Werner	1971-1972
3/14	Brehmer, Werner	1972-1973
3/15	Brehmer, Werner	1973
4/1	Brehmer, Werner	1974-1975
4/2	Brehmer, Werner	1975-1976
4/3	Brehmer, Werner	1976
4/4	Brehmer, Werner	1976
4/5	Brehmer, Werner	1977
4/6	Brehmer, Werner	1977-1978
4/7	Brehmer, Werner	1978-1979
4/8	Brehmer, Werner	1979
4/9	"B" Miscellaneous	1950-1961
4/10	"B" Miscellaneous	1960-1968
4/11	"B" Miscellaneous	1964-1972
4/12	"B" Miscellaneous	1974-1979
4/13	"B" Miscellaneous	1981-1986
5/1	Cantrell, John-Williams, Jim	1979
5/2	"C" Miscellaneous	1954-1961
5/3	"C" Miscellaneous	1962-1968
5/4	"C" Miscellaneous	1968-1973
5/5	"C" Miscellaneous	1973-1979
5/6	"C" Miscellaneous	1981-1982
5/7	"C" Miscellaneous	1984-1985
5/8	D'Aoust, Joan	1984
5/9	Davis, Dorland	1964-1976
5/10	Davis Primate Experiment	1966
5/11	Davis Primate Experiment	1965-1966
5/12	Davis Primate Experiment	1967-1972
5/13	Davis Primate Experiment	1972
5/14	Difco	1956-1972
5/15	DiLuzio, N. R.	1976
6/1	"D" Miscellaneous	1953-1961
6/2	"D" Miscellaneous	1962-1968
6/3	"D" Miscellaneous	1968-1979
6/4	"D" Miscellaneous	1984-1986
6/5	"E" Miscellaneous	1951-1961
6/6	"E" Miscellaneous	1962-1967
6/7	"E" Miscellaneous	1969-1979
6/8	"E" Miscellaneous	1985
6/9	Fales, Henry M.	1972
6/10	Fine, Jacob	1964-1967
6/11	Fukushi, Kazue	1960-1968
6/12	Fukushi, Kazue	1966-1978
6/13	"F" Miscellaneous	1951-1961
6/14	"F" Miscellaneous	1962-1966
6/15	"F" Miscellaneous	1966-1972
6/16	"F" Miscellaneous	1974-1978
6/17	"F" Miscellaneous	1980-1985
7/1	Goode, Dan	undated
7/2	Goren, Mayer	1971-1973
7/3	Goren, Mayer	1973-1975
7/4	Goren, Mayer	1973-1976
7/5	Granatek-Gutterman-Hersh	1974-1976
7/6	Granatek-Gutterman-Hersh	1976
7/7	Granatek-Gutterman-Hersh	1976
7/8	Granatek-Gutterman-Hersh	1975-1977
7/9	Granatek-Gutterman-Hersh	1977
7/10	Granatek-Gutterman-Hersh	1976-1979
7/11	Granatek-Gutterman-Hersh	1979
7/12	Granatek, Christine	1980-1983
7/13	Gray, Gary	1972-1975
7/14	Gray, Gary	1975
7/15	Gray, Gary	1975-1976
8/1	Gray, Gary	1976-1977
8/2	Gutterman-Hersh	1977-1979
8/3	Gutterman-Hersh	1980
8/4	"G" Miscellaneous	1951-1960
8/5	"G" Miscellaneous	1961-1965
8/6	"G" Miscellaneous	1962-1973
8/7	"G" Miscellaneous	1973
8/8	"G" Miscellaneous	1973-1977
8/9	"G" Miscellaneous	1977-1979
8/10	"G" Miscellaneous	1980-1986
8/11	Harris, S. C.	1980
8/12	"H" Miscellaneous	1967-1979
8/13	H" Miscellaneous	1984-1986
8/14	"H" Miscellaneous	1950-1961
8/15	"H" Miscellaneous	1963-1967
9/1	Imaeda, Dr. Tamotsu	1966-1967
9/2	Imaeda, Dr. Tamotsu	1967-1972
9/3	Infection and Immunity	1976-1977
9/4	Infection and Immunity	1976-1979
9/5	Infection and Immunity	1978-1979
9/6	Isenberg, Dr. Henry	1961-1974
10/1	Ivan Sorvall Incorporated Cell Fractionator	1958-1960
10/2	Ivan Sorvall Incorporated Cell Fractionator	1950-1961
10/3	Ivan Sorvall Incorporated Cell Fractionator	1961
10/4	Ivan Sorvall Incorporated Cell Fractionator	1962
10/5	Ivan Sorvall Incorporated Cell Fractionator	1962-1963
10/6	Ivan Sorvall Incorporated Cell Fractionator	1963
10/7	Ivan Sorvall Incorporated Cell Fractionator	1964-1965
10/8	Ivan Sorvall Incorporated Cell Fractionator	1965-1966
10/9	Ivan Sorvall Incorporated Cell Fractionator	1966
10/10	Ivan Sorvall Incorporated Cell Fractionator	1967
10/11	Ivan Sorvall Incorporated Cell Fractionator	1967-1972
10/12	Ivan Sorvall Incorporated Cell Fractionator	1972-1973
11/1	"I" Miscellaneous	1958-1974
11/2	"I" Miscellaneous	1984
11/3	Jenkin, Howard M. Ph.D.	1971
11/4	"J" Miscellaneous	1957-1971
11/5	"J" Miscellaneous	1973-1979
11/6	"J" Miscellaneous	1983-1985
11/7	Kato, Dr. Masahiko	1972-1976
11/8	Kelly, Michael	undated
11/9	Koffler, Dr. Henry	1957-1960
11/10	Koffler, Dr. Henry	1959-1960
12/1	Koffler, Dr. Henry	1959-1960
12/2	"K" Miscellaneous	1950-1963
12/3	"K" Miscellaneous	1964-1968
12/4	"K" Miscellaneous	1969-1970
12/5	"K" Miscellaneous	1970-1979
12/6	"K" Miscellaneous	1977
12/7	"K" Miscellaneous	1980-1986
12/8	Lackman, David	1975-1984
12/9	Landy, Dr. Maurice	1966-1973
12/10	Larson, Dr. Carl L.	1961-1963
12/11	Larson, Dr. Carl L.	1963-1964
12/12	Larson, Dr. Carl L.	undated
12/13	Lederer, Dr. Edgar	undated
12/14	Lederer, Dr. Edgar	1980
13/1	Luderitz, Milner, Niwa	1968-1971
13/2	"L" Miscellaneous	1951-1961
13/3	"L" Miscellaneous	1962-1974
13/4	"L" Miscellaneous	1971-1973
13/5	"L" Miscellaneous	1982-1985
13/6	Manuscript Reviews	1984-1985
13/7	Malmgren, Heden	1963-1966
13/8	Matsumoto, Dr. Junjiro	1969-1971
13/9	McGrady, Pat	undated
13/10	McLauglin, Dr. Charles DVM, Ph.D.	1974
13/11	McLauglin, Dr. Charles DVM, Ph.D.	1976-1977
13/12	McLauglin, Dr. Charles DVM, Ph.D.	1978
13/13	Medora, Rustem	1972
13/14	Meyer, K.F. M.D.	1970-1972
13/15	Microbial Toxins, 8th World Congress	Aug. 1985
13/16	Middlebrook, Gardner M.D.	1967-1968
13/17	Milner, Kelsey	1963-1968
13/18	Milner, Kelsey	1968-1973
14/1	Mitchell, M. S.	1980
14/2	Mizuno, Yuske	1976-1978
14/3	Morton, Harry	1956
14/4	Munoz, John J.	1958
14/5	Muraoka, Susy	undated
14/6	"M" Miscellaneous	1951-1961
14/7	"M" Miscellaneous	1963-1966
14/8	"M" Miscellaneous	1966-1972
14/9	"M" Miscellaneous	1971-1978
14/10	"M" Miscellaneous	1973-1977
14/11	"M" Miscellaneous	1978-1979
14/12	"M" Miscellaneous	1980-1984
14/13	"M" Miscellaneous	1984-1986
14/14	Nauts, Helen C.	1977-1978
14/15	Neter, Erwin	1965-1970
14/16	Nikaido, Hiroshi	undated
15/1	Niwa, Makoto	undated
15/2	Niwa, Makoto	1965-1968
15/3	Niwa, Makoto	1968-1978
15/4	Noll and Braude	1961-1963
15/5	Noll and Braude	undated
15/6	Norling, Annalisa	1957-1965
15/7	Nowotny, A.H.	undated
15/8	Nowotny, A.H.	1959-1960
15/9	Nowotny, A.H.	1960-1962
15/10	Nowotny, A.H.	1965
15/11	Nowotny, A.H.	1975-1979
15/12	"N" Miscellaneous	1951-1979
15/13	"N" Miscellaneous	1983-1986
15/14	Oucherlony, O.	1970-1972
15/15	"O" Miscellaneous	1955-1977
15/16	"O" Miscellaneous	1980-1984
16/1	Dagand	1982-1983
16/2	Patents	1984
16/3	Pertline, T.D.	1957-1962
16/4	"P" Miscellaneous	1951-1976
16/5	"P" Miscellaneous	1971-1979
16/6	"P" Miscellaneous	1976-1983
16/7	Ribi, E.	1949
16/8	Ribi, E.	April-September 1981
16/9	Ribi, E.	October-December 1981
16/10	Ribi, E.	January-June 1982
16/11	Ribi, E.	July-November 1982
16/12	Ribi, E.	November-December 1982
16/13	Ribi, E.	1983
16/14	Ribi, E.	1984
16/15	Ribi, E.	1985
16/16	Ribi, E.	1986
17/1	Richman	1978-1979
17/2	Rudbach, Jon A.	1963-1971
17/3	"R" Miscellaneous	1950-1966
17/4	"R" Miscellaneous	1965-1966
17/5	"R" Miscellaneous	1967-1977
17/6	"R" Miscellaneous	1977-1978
17/7	"R" Miscellaneous	1983-1985
17/8	Salvin, Samuel B.	1964-1986
17/9	Schmidt, Davis	1966
17/10	Seal, Dr. John	1966-1967
17/11	Seal, Dr. John	1966-1977
17/12	Shands, Joeseph W.	1962-1964
17/13	Shilo, Moshe	1963-1965
17/14	Small business Innovation Research	1983-1984
17/15	Small Business Innovation Research	1984
17/16	Smith, David, T.	1959-1971
18/1	Smith, Donald	1959-1966
18/2	Smith, Donald	1966-1967
18/3	Smith, Donald	1966-1973
18/4	Smith, Donald	1968
18/5	Smith, Ian	1963-1964
18/6	Sobel-Janicki	1969-1972
18/7	Sorkin, Ernst	1961
18/8	Sorkin, Ernst	1962-1963
18/9	Spink, Dr. Wesley	1964
18/10	Stewart, Gwen	1962
18/11	Strain, Mike	1961-1976
18/12	Suzuki, F.	1981
18/13	"S" Miscellaneous	1952-1961
18/14	"S" Miscellaneous	1959-1965
19/1	"S" Miscellaneous	1965-1972
19/2	"S" Miscellaneous	1972-1977
19/3	"S" Miscellaneous	1978-1979
19/4	"S" Miscellaneous	1980-1986
19/5	Takayama, Kuni	1975-1976
19/6	Takayama, Kuni	1977
19/7	Tarmina, David	1964-1976
19/8	Tauber, Henry	1960-1962
19/9	Toubiana, Raoul	1975-1978
19/10	Toubiana, Raoul	1975-1978
19/11	Toubiana, Raoul	1975-1978
19/12	Toubiana, Raoul	1975-1978
19/13	Toubiana, Raoul	1975-1978
19/14	Toubiana, Raoul Review	undated
19/15	Toubiana, Raoul Review	undated
20/1	"T" Miscellaneous	1958-1979
20/2	"T" Miscellaneous	1980-1985
20/3	United States Department of Agriculture	1983
20/4	"U" Miscellaneous	1956-1983
20/5	Von Eschen	undated
20/6	Von Eschen	undated
20/7	Von Eschen	undated
20/8	Von Eschen	undated
20/9	Von Eschen	undated
20/10	Von Eschen	undated
20/11	Von Eschen	undated
20/12	Von Eschen	undated
20/13	Vosicka, Gerald	1977-1979
20/14	Vosicka, Gerald	1977-1979
20/15	Vosicka, Gerald	1977-1979
21/1	Vosicka, Gerald	1978-1979
21/2	Vosicka, Gerald	1979
21/3	Vosicka, Gerald	1979
21/4	"V" Miscellaneous	1962-1975
21/5	"V" Miscellaneous	1975-1985
21/6	Walker, Robert	1975
21/7	Ward, Jack	1985-1986
21/8	Watson, Dennis W.	1960-1964
21/9	Weibull, Claes	1959-1964
21/10	Weibull, Claes	1961-1965
21/11	Weibull, Claes	1966-1973
21/12	Weibull, Claes	1982-1983
21/13	Wepsic, Terry	1975-1977
21/14	Westphal, Otto	1959-1967
21/15	Wheat, Robert	1963-1971
21/16	Wheat, Robert	1968
21/17	Williams, Curtis A.	1964-1966
22/1	Williams, Jim	1978
22/2	Winters, Wendall	1978-1979
22/3	Winters, Wendall	undated
22/4	Wright, G.L.	1972-1974
22/5	"W" Miscellaneous	1953-1965
22/6	"W" Miscellaneous	1965-1975
22/7	"W" Miscellaneous	1975
22/8	"W" Miscellaneous	1975-1979
22/9	"W" Miscellaneous	1981-1985
22/10	Yamamoto, Ken-Ichi	1967-1976
22/11	Yamamoto, Ken-Ichi	1974-1985
22/12	Yarkoni, Eliyahu	1980
22/13	"Y" Miscellaneous	1959-1975
22/14	"Y" Miscellaneous	1983-1984
22/15	"Z" Misc	1982
22/16	Miscellaneous	undated

Series III: Research Files, 1953-1980Return to Top

51 linear feet

This series contains extensive research records generated or collected by Edgar Ribi. Series materials were generated throughout Ribi's academic and professional career; however, the largest portion date from the period of Ribi's employment at the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana. These files provide detailed documentation of hypotheses, procedures, results (including multi-variable data charts), and adjustments from Ribi's work and those of his colleagues in the field of immunology and infectious disease research.

Container(s)	Description	Dates
Box/Folder
23/1	Skin Tests No. 1
23/2	Skin Tests No. 2
23/3	Bob List No. 2
23/4	Bob List No. 3
23/5	Bob List No. 5
23/6	Bob List No. 4
24/7	Bob List No. 6
24/8	Toxicity Tests No. 1
24/9	Toxicity Tests No. 2
24/10	Toxicity Tests No. 3
24/11	Salmonella Se 31-62 No. 3
24/12	Salmonella Se 63-Se 101 No. 4
25/13	Salmonella Se 102-Se 126 No. 5
25/14	Salmonella Se 127-Se 147 No. 6
25/15	Salmonella Se 148-Q 1 # Q No. 7
25/16	Histo Salmonella Se 1-Se 30 No. 2
25/17	Electron Micrographs Electron Microscope Int. Copies
25/18	Electron Micrographs II Electron Microscope 186-368 No. 2
26/19	Electron Micrographs III Electron Microscope 369-539 No. 3
26/20	Electron Micrographs IV Electron Microscope 540-720 No. 4
26/21	Electron Micrographs V 721
26/22	Electron Microscope No. 1
26/23	Siemens No. 1
26/24	Thuli Histo Crypto Ribi No. 1
26/25	Electrophoresis
27/26	X-Ray Diffraction
27/27	Bethesda-Uppsala
27/28	Endotoxins, Haskins 1
27/29	Endotoxins, Haskins 2
27/30	Endotoxins, Hasknis 3
27/31	Endotoxin Fractionation, Dan Goode
28/32	Myc. Protoplasm Fractionations
28/33	Cell Walls, Simmons
28/34	Cell Walls, Simmons
28/35	Protection to Tuberculosis Male Guinea Pig 's
28/36	ERIC I
28/37	ERIC II
29/38	Cultures No. 1
29/39	Seed Cultures List No. 2
29/40	Bioassays
29/41	B. Pertussis
29/42	B. Tularense
29/43	FDA BCG-Cell Wall Skeletons
29/44	BCG Parvum
30/45	E. Coli II
30/46	R. Anderson
30/47	Nitrogen Det., Dan Goode
30/48	Rickettsiae, Neaves No.1
30/49	Q-Fever
30/50	S. Minnesota R595
31/51	S. Marcescens
31/52	Sty 17 and others
31/53	Strep
31/54	Tuberculosis, Ribi, List 1, No. 1
31/55	Sample Distribution	1976
31/56	Notes	1973, 1978, 1979
32/57	Personal Letter- Spritznagel, DuBois
32/58	Various Extractions Experiments Jim Simmons
32/59	Alkaline Degradation of Endotoxin, M. Niwa
33/60	Endotoxins Chemical Analyses I
33/61	Endotoxins Chemical Analyses II
33/62	Endotoxin-Bioassays I; Correspondences - Dr. Landy
34/63	Endotoxin-Bioassays II; Correspondence-Dr. Landy
34/64	Endotoxin-Bioassay III; Correspondence-Landy, Suter, Smith
34/65	Endotoxins IV
35/66	Endotoxins V
35/67	Endotoxins VI
35/68	Endotoxins VII
36/69	Ultracentrifugation Record I
36/70	Endotoxins, Ultracentrifugation I
36/71	Endotoxins, Ultricentrifugation II
37/72	Ultricentrifugation III
37/73	Endotoxins Physical Measurements I
37/74	Endotoxins Planned Work
38/75	Experiment of Endotoxin from S. Typhinimurium, K. Amano
38/76	Tuberculosis
38/77	T.B, Mouse Protection Tests	1965
39/78	Tuberculosis Summary Data	1965-1966
39/79	Tuberculosis Miscellaneous Proposal for Experiment
40/80	Tuberculosis Protection Tests	1966
40/81	Tuberculosis Summary Data	1967
40/82	Tuberculosis Protection Tests	1967
41/83	Tuberculosis Protection Tests	1968
41/84	Tuberculosis Protection Tests	1968-1969
41/85	Tuberculosis Protection Tests	1969
42/86	Tuberculosis Protection Tests	1970
42/87	Tuberculosis Protection Tests	1970
42/88	Tuberculosis Protection Tests	1971
43/89	Tuberculosis Protection Tests	1972
43/90	Granuloma Experiment	1972-1973
43/91	Tuberculosis Protection Tests	1972-1973
44/92	Tuberculosis Protection Tests	1973
44/93	Tuberculosis Protection Tests	1974
44/94	Tuberculosis Protection Tests	1974
45/95	Tuberculosis Protection Tests	1975
45/96	Experiments	1978
45/97	Protection and Granuloma	1975
46/98	Tuberculosis Centrichrome	1971
46/99	Tuberculosis Centrichrome	1970
46/100	Tuberculosis Centrichrome
47/101	Pyrogen Tests, P.3-3-77, P.4-25-77
47/102	Pyrogen Tests	4-29-1977, 6-6-1977
47/103	Current
48/104	Pyrogen Tests, 1	6-13-1977, 8-1-1977
48/105	Pyrogen Tests, 3	10-28-1977, 11-28-1977
48/106	Pyrogen Tests, 6	3-17-1978, 4-28-1978
49/107	Pyrogen Tests, 7	5-3-1978, 7-7-1978
49/108	Pyrogen Tests, 8	7-10-1978, 8-18-1978
49/109	Pyrogen Tests, 9	8-21-1978, 10-23-1978
50/110	Toxicity and Pyrogen Tests, ET	1978-1979
50/111	Pyrogen Tests, 10	10-27-1978, 12-22-1978
50/112	Pyrogen Tests, 11	1-5-1979, 2-26-1979
51/113	Pyrogen Tests, 12	3-2-1979, 4-20-1979
51/114	Pyrogen Tests, 13	4-23-1979, 6-8-1979
51/115	Pyrogen Tests, 14	6-11-1979, 7-27-1979
52/116	Pyrogen Tests, 15	8-3-1979, 9-21-1979
52/117	Pyrogen Tests, 16	9-28-1979, 11-16-1979
52/118	Pyrogen Tests, 17	11-19-1979, 12-28-1979
53/119	Pyrogen Tests, 18	1-15-1980, 2-26-1980
53/120	Sugars I
53/121	Endotoxin Detergent I
54/122	Methyl Pentose, Citric Acid
54/123	Nucleic Acid Analysis
54/124	Hexose
55/125	Hexosamine	1961-1969
55/126	Heptose Detn
55/127	Hexose	1961-1969
56/128	Total Carbohydrate	1962-1969
56/129	Smack-Heroin
56/130	Smack-Heroin, Literature
57/131	Smack-Heroin, Literature
57/132	KDO-DDS Old Method
57/133	Niotrogen	1961-1965
58/134	Phosphorus	1961-1965
58/135	KDO-DDS
58/136	Hexosamine
59/137	Fatty Acids
59/138	Fatty Acids	1961-1969
59/139	Tumor Work Notes I
60/140	Tumor Work Notes II
60/141	Guinea Pig Gran. Tumor Suppression, MIF, Regression	1974-1979
60/142	Tumor Cell Experiment
61/143	Raffel-Mackaness
61/144	Toxicity Tests	1974 Orley, Results and Protocals
61/145	Landy
62/146	M. Strain
62/147	M. Strain
62/148	M. Strain
63/149	M. Strain	January 1976, January 1978
63/150	Parke, Davis and Company
63/151	Dr. Philip Gerhardt
64/152	Malmgren
64/153	Dr. Erwin Neter
64/154	Soren Orley
65/155	Ichiro
65/156	Dayli Notes
65/157	AAA, Beckman
66/158	Centrichrome BCG No. 1
66/159	Centrichrome
66/160	Centrichrome, Pesticides
66a/161	Whole Cell Extracts, P.3, CHcl3 Experiment's
66a/162	Autorediography
66a/163	Electron Microscope Photos, Tumor. K. Fukushi
66b/164	Line 10 and Regl-Pec Photos
66b/165	Ragweed Pollen Antigens Ultracentrifuge III Mycobacterial Culture Book 2, 12-21-77-, Code No.336
66c/167	Mycobacterial Culture Record	4-27-1973, 12-15-1977
66c/168	Culture Records
66c/169	B4 Studies
66d/170	Summary Chemical Analysis
66d/171	Lipids Studies
66d/172	Total Carbohydrate
66e/173	Pseudogen
66e/174	Immunization Records, Antisera
66e/175	Nonspecific Experiments No. 305-396
66f/176	Toxicity Tests	6-22-1979, 11-22-1978
66f/177	Bioassays, Others
66f/178	Collaborations Experiment Summary
67/179	CELD 50, No. 1	6-14-1977, 7-26-1978
67/180	CELD 50, No. 2	8-1-1978, 5-29-1979
67/181	CELD 50, No. 3	6-5-1979, 7-22-1980
68/182	CELD 50, No. 4	8-4-1950
68/183	P. Pestis
68/184	Others	10-28-1977
69/185	Miscellaneous Charts
69/186	Miscellaneous Charts
69/187	Miscellaneous Charts
70/188	S. Marescus
70/189	Pyrogen Summary
70/190	Endotoxins, Others, Correspondences
71/191	Miscellaneous Papers
71/192	Experimentsl Results
71/193	Autoclave Charts
71/194	United States Department of Agriculture License Applications
72/195	Protocol Book
72/196	G.B. Mackaulss, Cellular Immunity
72/197	Notes, Addresses
72/198	Miscellaneous Notes
72/199	Notes, Study, Preparation for Boulder Colorado	1958
72/200	D2o Exchange from Bern
72/201	More Notes from Bern
73/1	Notes for Future Centrichhrome Publications
73/2	Notes - Centrifigul Chromotography
73/3	Notes, Miscellaneous, Centrichrome Review; Marijuana
73/4	M.S., Affinity Chromtography
73/5	Chromotography
73/6	High Speed Liquid Chromotography
73/7	H.S.L. Chromo
73/8	H.S.L. Chromo
73/9	Centri - Chromo
73/10	Centri - Chromo
74/1	Chromo Reprints
74/2	Chromo Reserve Copies, Pictures
74/3	TLC Centri-Chromo Germicides, Rhoades
74/4	Endotoxins Centri-Chrome	1970
74/5	Centri-Chrome Procedures
74/6	Marijuana: Cannabinoids by Centri-Chromo
74/7	Chromo's from Syp. on Bacteria Endotoxins SAB	1961
74/8	Centri-Chromo Diagram
74/9	Centri-Chromo Protocols, Results, IS Manual
74/10	Chromo - Lipids
74/11	Centri-Chromo
74/12	Chromo Results
74/13	Chromo Results
75/1	Centri-Chromo Subfractions V.I Book 2
75/2	Centri-Chromo Subfractions V.I Book 2
75/3	Centri-Chromo Subfractions V.I Book 3
75/4	Centri-Chromo Subfractions V.I Book 3
75/5	Centri-Chromo Subfractions V.II Book 4
75/6	Centri-Chromo Subfractions V.II Book 4
75/7	Centri-Chromo Subfractions V.II Book 5
75/8	Centri-Chromo Subfractions V. II Book 5
76/1	Centri-Chromo Subfractions V.III Book 6
76/2	Centri-Chromo Subfractions V. III Book 6
76/3	Centri-Chromo Subfractions V. III Book 7
76/4	Centri-Chromo Subfractions V. III Book 7
76/5	Centri-Chromo Subfractions V. IV Book 8
76/6	Centri-Chromo Subfractions V. IV Book 8
76/7	Centri-Chromo Subfractions V. IV Book 9
76/8	Centri-Chromo Subfractions V. IV Book 9
76/9	Centri-Chromo Subfractions V. V Book 10
77/1	Centri-Chromo Subfractions V. V Book 10
77/2	Centri-Chromo Subfractions V. V Book 11
77/3	Centri-Chromo Subfractions V. V Book 11
77/4	Centri-Chromo Photos
77/5	Centri-Chromo Photos/Results
77/6	Centri-Chromo Photos No. 30
77/7	Centri-Chromo Photos/Graphs No. 29
77/8	Centri-Chromo Photos No. 28
77/9	Centri-Chromo Paper No. 26
77/10	Centri-Chromo Photos/Figures No. 25
77/11	Centri-Chromo Figures 23,24,22,21,20,19,8,2,1,37,36,34,33,31,32,9,12
77/12	Centri-Chromo Figures 11,10,6,7,13,35,2,27,14,15,18,17
77/13	Centri-Chromo Steroids
77/14	Centri-Chromo Marijuana
77/15	Centri-Chromo Dr. Milner
78/1	Guinea Pig Skin Tests	7-29-1977
78/2	Guinea Pig - P3 Toxicity EO20775-T
78/3	Guinea Pig Toxin Tests
78/4	Guinea Pig Experiments 11-2-67 and 11-4-68 Undependable Results
78/5	Guinea Pig 4-3-68
78/6	Guinea Pig Tumor 092680R
78/7	Guinea Pig 103180R
78/8	Guinea Pig Tumor 101080R
78/9	Guinea Pig Tumor 100380R
78/10	Guinea Pig Tumor 091280R
78/11	Guinea Pig Tumor 090580R
78/12	Guinea Pig Tumor 032180R
78/13	Guinea Pig Tumor 082280R
78/14	Guinea Pig Tumor 082980R
78/15	Guinea Pig Tumor 081580R
78/16	Guinea Pig Tumor 081480R
78/17	Guinea Pig Tumor 080180R
78/18	Guinea Pig Tumor 071880R
78/19	Guinea Pig Tumor 060680R
78/20	Guinea Pig Tumor 062780R
78/21	Guinea Pig Tumor 070380R
78/22	Guinea Pig Tumor 061380R
78/23	Guinea Pig Tumor 102480R
78/24	Guinea Pig Tumor 110780R
78/25	Guinea Pig Tumor 041379R
78/26	Guinea Pig Tumor 010480R
78/27	Guinea Pig Tumor 053080R
78/28	Guinea Pig Tumor 052380R
78/29	Guinea Pig Tumor 050980R
78/30	Guinea Pig Tumor 050280R
78/31	Guinea Pig Tumor 042580R
78/32	Guinea Pig Tumor 041880R
78/33	Guinea Pig Tumor 041180R
78/34	Guinea Pig Tumor 032880R
78/35	Guinea Pig Tumor 031480R
78/36	Guinea Pig Tumor 022980R
78/37	Guinea Pig Tumor 021580R
78/38	Guinea Pig Tumor 020880R
78/39	Guinea Pig Tumor 012580R
79/1	Bethesda Tumor Experiment 1st Production of Tumor Immunology
79/2	Bethesda Tumor Experiment 1st Regsn of Pre-est. Tumor
79/3	Guinea Pig Tumor Regression Experiments
79/4	Tumor Experiment
79/5	Vaccine Preparation
79/6	Tumor Regression Experiment
79/7	Mouse Tumor Protocol
79/8	Tumor System Protocol
79/9	Summary Tables
79/10	Guinea Pig Tumor 122879R
79/11	Guinea Pig Tumor 113079 Swartzman
79/12	Guinea Pig Tumor 112379R
79/13	Guinea Pig Tumor 101979R
79/14	Guinea Pig Tumor 092779R
79/15	Guinea Pig Tumor 083179R
79/16	Guinea Pig Tumor 080379R
79/17	Guinea Pig Tumor 072079R
79/18	Guinea Pig Tumor 070679R
79/19	Guinea Pig Tumor Experiment 073179R
79/20	Guinea Pig Tumor 060879R
79/21	Guinea Pig Tumor 060179R
79/22	Guinea Pig Tumor 051879R
79/23	Guinea Pig Tumor 042779R
79/24	Guinea Pig Tumor 033079R
79/25	Guinea Pig Tumor 031679 Cantrell
79/26	Guinea Pig Tumor 030279R
80/1	Guinea Pig Tumor 022379R
80/2	Guinea Pig Tumor 020279R
80/3	Guinea Pig Tumor 012679R
80/4	Guinea Pig Tumor 010579R
80/5	Guinea Pig Tumor 120878R
80/6	Guinea Pig Tumor 110978R
80/7	Guinea Pig Tumor 102078R
80/8	Guinea Pig Tumor 092278R
80/9	Guinea Pig Tumor 090178R
80/10	Guinea Pig Tumor 081878RC
80/11	Guinea Pig Tumor 072878R
80/12	Guinea Pig Tumor 063078R
80/13	Guinea Pig Tumor 122878R
80/14	Guinea Pig Tumor 100777R
80/15	Guinea Pig Tumor 072277R
80/16	Guinea Pig Tumor 040877R
80/17	Guinea Pig Tumor 101576-I Cantrell
80/18	Guinea Pig Tumor 052076R
80/19	Guinea Pig Tumor 051376R
80/20	Guinea Pig Tumor 042176R
80/21	Guinea Pig Tumor 012876R
80/22	Guinea Pig Tumor 122475R
80/23	Guinea Pig Tumor 121175R
80/24	Guinea Pig Tumor 120375R
80/25	Guinea Pig Tumor 103075R
80/26	Guinea Pig Tumor 100275R
80/27	Guinea Pig Tumor 092475R
80/28	Guinea Pig Tumor 082075R
80/29	Guinea Pig Tumor 081275R
80/30	Guinea Pig Tumor 072575R
80/31	Guinea Pig Tumor 071775R
80/32	Guinea Pig Tumor Experiment 070975R
80/33	Guinea Pig Tumor Experiment 070375R
80/34	Guinea Pig Tumor 060575R
80/35	Guinea Pig Tumor 052375R
80/36	Guinea Pig Tumor 050775R
80/37	Guinea Pig Tumor 041675R
80/38	Guinea Pig Tumor 040375R
80/39	Guinea Pig Tumor 022775R
80/40	Guinea Pig Tumor 0214759
80/41	Guinea Pig Tumor 020575R
80/42	Guinea Pig Tumor Experiment 012275R
80/43	Guinea Pig Tumor 011674 $
80/44	Guinea Pig Tumor 010275R
80/45	Guinea Pig Tumor 122074R
81/1	Guinea Pig Tumor Experiment 121974R
81/2	Guinea Pig Tumor121174R
81/3	Guinea Pig Tumor 120374R
81/4	Guinea Pig Tumor Experiment 112974 $
81/5	Guinea Pig Tumor 111974R
81/6	Guinea Pig Tumor 110674R
81/7	Guinea Pig Tumor 102374R
81/8	Guinea Pig Tumor Experiment 101674R
81/9	Guinea Pig Tumor Experiment 100174R
81/10	Guinea Pig Tumor Experiment 092474R
81/11	Guinea Pig Tumor Experiment 090574R
81/12	Guinea Pig Tumor Experiment 082274R
81/13	Guinea Pig Tumor Females Experiment 082074 $
81/14	Guinea Pig Tumor 072974R
81/15	Guinea Pig Tumor 071874R
81/16	Guinea Pig Tumor 071174R
81/17	Guinea Pig Tumor 070274R
81/18	Guinea Pig Tumor Experiment 062774R
81/19	Guinea Pig Tumor 060574R
81/20	Guinea Pig Tumor 050374 $
81/21	Guinea Pig Tumor 051674R
81/22	Guinea Pig Tumor 050874R
81/23	Guinea Pig Tumor 050274 $
81/24	Guinea Pig Tumor Experiment 042574 $
81/25	Guinea Pig Tumor 042274R
81/26	Guinea Pig Tumor Experiment 040174R
81/27	Guinea Pig Tumor 032074 $, L10, TC's, T. Spiralis- Granger
81/28	Guinea Pig Tumor Experiment 031574 $
81/29	Guinea Pig Tumor 022274R
81/30	Guinea Pig Tumor Experiment 022174 $
81/31	Guinea Pig Tumor Experiment 021274 $
81/32	Guinea Pig Tumor Experiment 020574 $
81/33	37RV on L10 Guinea Pig T 02-1974
81/34	Guinea Pig Tumor Experiment 010374 $
81/35	Guinea Pig Tumor Experiment 012274R
81/36	Guinea Pig Tumor Experiment 010874 $
81/37	Guinea Pig Tumor Pt.1 Experiment 122173, Pt.2 Experiment 122773
81/38	Guinea Pig Tumor Experiment 122173 TG 041675
81/39	Guinea Pig Tumor Experiment 120773R
81/40	Guinea Pig Tumor Experiment 120573R
81/41	Guinea Pig Tumor Experiment 110973 TG Brehmer
81/42	Guinea Pig Tumor Experiment 091973R
81/43	Guinea Pig Tumor 091873
81/44	Guinea Pig Tumor 091173R
81/45	Guinea Pig Tumor Male/Female 082373
82/1	Guinea Pig Tumor Female Experiment 070373
82/2	Guinea Pig Tumor Male 071173
82/3	Guinea Pig Tumor Experiment 061273
82/4	Guinea Pig Tumor Female Experiment 052473
82/5	Guinea Pig Tumor Male Experiment 050273
82/6	Guinea Pig Tumor Experiment 041173 Hartley
82/7	Guinea Pig Tumor Male Experiment 040473
82/8	Guinea Pig Tumor Male Experiment 031273
82/9	Guinea Pig Tumor Female Pt.1 021373, Pt.2 022273
82/10	Guinea Pig Tumor Female Experiment Experiment 020273
82/11	Guinea Pig Tumor Male 010273
82/12	Guinea Pig Tumor Male 121172
82/13	Guinea Pig Tumor Male 101672
82/14	Guinea Pig Tumor 101072
82/15	Guinea Pig Tumor Male 103172
82/16	Guinea Pig Tumor Female 081472
82/17	Guinea Pig Tumor Female 081072
82/18	Guinea Pig Tumor Female 072972
82/19	Guinea Pig Tumor 072672 To Be Challenged
82/20	Guinea Pig Tumor Female 062872
82/21	Guinea Pig Tumor Male 062872
82/22	Guinea Pig Tumor Female/Male 051872
82/23	Bethesda Tumor Experiment 042572
82/24	Guinea Pig Tumor 031472 II
82/25	Guinea Pig Tumor 031472 I
82/26	Guinea Pig Tumor 020372 BCG-115, BCG-102
82/27	Guinea Pig Tumor Summary Data
82/28	Proposed Tumor Experiments
83/1	University At Bern Russian Language Document
83/2	University at Bern Quantitative Analyse
83/3	University at Bern Chitin
83/4	University at Bern Notebooks	[1940-1949]
83/5	University at Bern Notebooks
83/6	University at Bern Notebooks
83/7	University at Bern College Papers/Notes
84/1	University at Bern Augszug der Organischen Chemie I
84/2	University at Bern Electron Microscope 1940's
84/3	University at Bern Swiss Scientists Assn
84/4	University at Bern Bericht NR.5 (e)
84/5	University at Bern Bericht NR.4 (d)
84/6	University at Bern Bericht NR.6 (c)
84/7	University at Bern MN-AL Dopplehydroxide und Bas. Dopplechlorid (b)
84/8	University at Bern Papers (a of the sequence)
84/9	University at Bern Physical Chemie 77282 K 7.50
84/10	University at Bern Einfuring in die Qualitative Analyse
84/11	University at Bern Pharmazeutischer Analysen Allgemeines, Lituratur
85/1	University at Bern Mss. Manuscripts, Notes
85/2	University at Bern Biochemische Gesellschaft
85/3	University at Bern Cellulose Industries
85/4	University at Bern Oganische Chemie Vorlesung
85/5	University at Bern Differential U. Itegralrechnung
85/6	University at Bern Mineralogie
85/7	University at Bern Licht und Materie
86/1	University at Bern Dr. W. Feitknecht, Chemikerfachverein der Universitat Bern
86/2	University at Bern Eletorchemie Ribi IV
86/3	University at Bern Augszug der Organischer Chemie Ribi III
86/4	University at Bern Phsikklausur Ribi Pt.1
86/5	University at Bern Phsikklausur Ribi Pt.2
86/6	University at Bern Phsikklausur Ribi Pt.3
86/7	University at Bern Phsikklausur Ribi Pt.4
86/8	Universitat Bern Phsikkluasur Botanik Pt.5
86/9	University at Bern Cellulose Meetings
87/1	Electron Microscope
87/2	Phillips Experiment M Documents
87/3	Charts and Graphs for Schematics
87/4	Mechanical Drawings (B)
87/5	Mechanical Drawings (A)
87/6	Mechanical Drawings
87/7	Mechanical Drawings
87/8	Experiment M Studies of Rayon, Manuscripts
87/9	Electron Diffraction
88/1	Collaborations Larson Experiment
88/2	Collaborations Perrine Project
88/3	Collaborations Jim Simmons
88/4	Collaborations Jim Simmons Running Experiments
88/5	Collaborations Jim Simmons	1968
88/6	Collaborations Takayama, ET MS's No. 1
88/7	Collaborations U.S.-Japan, Program, Letters, Miscellaneous
88/8	Collaborations U.S.-Japan, Program, Letters, Miscellaneous
89/1	Collaborations Galanos Fractionation "1.03gr Lipid "A"
89/2	Collaborations J. U. Gutterman, M.D., University of Texas Literature
89/3	Collaborations D.L. Granger, Reports, Correspondence, Etc
89/4	Collaborations J.H. Hanks, Reports, Correspondence, Etc
89/5	Collaborations Hazelton Monkey Experiment 1 MS. May	1971
89/6	Collaborations Hazelton Monkey Necropsy Rpts
89/7	Collaborations L.B. Hinshaw, Ph.D. Reports Correspondence, Etc
89/8	Collaborations Hollister-Stier, Ragweed
89/9	Collaborations Dr. Kon Hwang, Reports Correspondence, Etc
89/10	Collaborations Key/Kuni B4, B4-4.5Ph, B4-HcL Data
89/11	Collaborations Kuni ACP	1978-1980
89/12	Collaborations Kuni Endotoxin Fractionation MS Reports	1980
89/13	Collaborations Kuni Early MCP Fractionation
89/14	Collaborations Kuni Lipid "A" Frations "1.14
90/1	Antigens-H.Caps; Immu. Props of Protplasm v. CW's
90/2	Distribution of Bacteria in Antigens
90/3	Amino Acids Analysis Results
90/4	Disruption of Bacteria for Preparation of Antigens, CW's
90/5	Arabinose Mycolate Research
90/6	Ultrastruct. - Enveloping Spores in B.Ceres
90/7	Batch Cultures No. 1 - No. 92
90/8	Batch Cultures No. 93- No. 185
90/9	Batch Cultures No. 186- No. 251
90/10	Batch Cultures No. 252- No. 283
91/1	Bed Processing, Microparticulate Silica
91/2	New Bed Processing, Micro. Silica
91/3	Antigens of Bordetella Pertussis
91/4	BCG-Rickettesial Infections, H.E.W. memos
91/5	BCG- CW Vaccine, T-S
91/6	BCG Production Yields
91/7	Preparationof Cell Wall Skeletons From BCG
91/8	BCG Misplaced
91/9	BCG Treatment of Melanoma
91/10	BCG Experiment's
91/11	Bioassays Composite
91/12	Canine Mammary, others
91/13	Canine Distemper, Measles, SSPE, Photos; NMS Society
91/14	Preparation for CW Vaccine
91/15	Cell Wall Organization of Plants
91/16	Charted Data
91/17	Column Experiment's Book 1
92/1	Demonstration
92/2	EDTA Treatment	1979-1980
92/3	ExperimentMycobat Btol. 322	10
92/4	Endotoxins Proposed
92/5	Reaction - Endotoxins and Surfactants	1966
92/6	Reaction - Endotoxins and Suractants	1966
92/7	Reaction - Endotoxins and Suractants	1966
92/8	Physical Aspects of Rev. Inactiv. of Endotoxins
92/9	EAExperiment Experiment	December 1974
92/10	Extract.and Puri. of Endotoxins from Enterobacteridceae
92/11	Reaction Endotoxins and Suractants I. Physical and Biochemical Props
92/12	New Attempt at Peptide Free Endotoxins	1964
92/13	Preparationof Micororganisms for Electron Microscope
92/13a	Electron Microscope Preps	1978
92/13b	Electron Microscope Exp's	1979
92/14	Origin/Properties of Naturally Occuring Hapten
92/15	Orgin/Properties of Naturally Occuring Hapten
92/16	Physical Structure of Native Hapten
92/17	Orgin/Properties of Naturally Occuring Hapten
93/1	Progress Reports	1977
93/2	Progress Reports	1979, 1980
93/3	Progress Reports	1976
93/4	Progress Reports	1974, 1975
93/5	Progress Reports RML	1974
93/6	Progress Reports	1973
93/7	Progress Reports	1972
93/8	Progress Reports RML	1970, 1971
93/9	Progress Reports SIE Tuberculosis	1971
94/1	Progress Reports	1970
94/2	Progress Reports Advisory Counsel	1970
94/3	Progress Reports	1969
94/4	Progress Reports	1968
94/5	Progress Reports	1966, 1967
94/6	Progress Reports RML Tuberculosis	1966
94/7	Progress Reports	1966
94/8	Progress Reports	1964
95/1	Progress Reports	1963
95/2	Progress Reports	1962
95/3	Progress Reports	1961
95/4	Progress Reports	1960
95/5	Progress Reports	1959
95/6	Progress Reports	1959
95/7	Progress Reports	1958
95/8	Progress Reports	1957
95/9	Progress Reports	1956
95/10	Progress Reports	1955
95/11	Progress Reports No Date
95/12	Progress Reports	1953
95/13	Progress Reports DCCP
96/1	Tuberculosis Research Committee	September 1969
96/2	Tuberculosis Statistical Analysis
96/3	Tuberculosis Statistics
96/4	Tuberculosis Abstracts, Reprints, and Correspondence
96/5	Tuberculosis Abstracts, Reprints, and Correspondence
96/6	Tuberculosis Correspondence
96/7	Tuberculosis Mouse Protection Tests	1964
96/8	Tuberculosis Mouse Protection Experiment BCG-77	November 1964
96/9	Tuberculosis Mouse Protection Experiment BCG-81	November 1964
96/10	Tuberculosis Mouse Protection Experiment BCG-80	September 1964
96/11	Tuberculosis Mouse Protection Experiment BCG-79	June 1964
96/12	Tuberculosis Mouse Protection Experiment BCG-76	June 1976
96/13	Tuberculosis Mouse Protection Experiment BCG-78 I, II, III	May 1964
96/14	Tuberculosis Mouse Protection Experiment BCG-78 I	May, June 1964
96/15	Tuberculosis Mouse Protection Experiment BCG-69
97/1	Tuberculosis Mouse Toxicity
97/2	Tuberculosis Methanol Extract, Negre; , Lembke
97/3	Tuberculosis
97/4	Tuberculosis Hypersensitivity H.E.W
97/5	Tuberculosis Resistance Stim'd by Fractions from Attenoated Tuberculosis
97/6	Tuberculosis Skin Reactions in Rabbits
97/7	Tuberculosis Skin Tests, Tuberculin, ppd
97/8	Tuberculosis Skin Test Results	8-24-1960
97/9	Tuberculosis Spec. Resistance to Tuberculosis and Salmonella in Mice by Oil CW's
97/10	Tuberculosis 88 Test, 2112 Rabbits	1976
97/11	Tuberculosis Rabbit Skin Test
97/12	Tuberculosis Research Committee	September 1969
97/13	Tuberculosis Youman's Literature
97/14	Tuberculosis Bad Publicity
98/1	Tuberculosis Experiment Tables
99/1	Antigens of Histoplasma Caps I
99/2	Glass Knives for Thin Sec. Microtomy
99/3	Granuloma Protection	1970-1974
99/4	Gran. Prot.	1970-1974
99/5	Gran. Prot.	1970-1974
99/6	Lactobaccilus Bifidus
99/7	Leprosy
99/8	Line 10 Tumor Regression Experiment Dosing
99/9	Line 10 Mss
99/10	Line 10 Tumor I
100/1	Spectrophometric Det. of Fatty Acids Amides in Lipids
100/2	Lipid Studies
100/3	Lipids, Toxins
100/4	Neutral Lipids Book No. 1
100/5	B4- Lipid "A" 100
100/6	Metabolic Effect of L."A" In Vitro Tox., Proposed
100/7	LMSF Notes, Ribi
100/8	Marijuana Literature, Chromo., Etc
100/9	Marijuana
100/10	Marijuana II, Mex. Male
100/11	Marijuana I, Mex. Female
100/12	Media
100/13	Methodology Manual-Mycobacterial/Fungal Antigens
100/14	Immu. Sign. of CW of Microbact
100/15	Mss. Lit
101/1	RandD Planning
101/2	RandD Planning
101/3	F.D.A
101/4	Publicity, Tumor Immunity
101/5	Products
101/6	Patent Material
101/7	Patent Matters
101/8	Notes, Laser Correspondence
101/9	BitterRoot Med. REs. Inst
101/10	Suggestions - Hans
101/11	Sorval-Ribi Abstracts
101/12	Ribi Intra-Co. Memos
101/13	Ribi Immu. RandD, Wheat and Takayama	1983
101/14	Structure/Function Relationship of Bacteria Endotoxins
102/1	Correspondence
102/2	Correspondence
102/3	Correspondence Veteran's Administration
102/4	Correspondence Mt. Trudeau Soc., Mt. Lung Association
102/5	Correspondence	1959
102/6	Correspondence	1961
102/7	Correspondence	1960
102/8	Correspondence	1963
102/9	Correspondence	1962
102/10	Correspondence	1964
102/11	Correspondence	1965
102/12	Correspondence Walker, Department of Environmental Science, Hobby-H.E.W
103/1	Endotoxins Literature/Correspondence
103/2	Correspondence
103/3	Correspondence Microbio. Assn's, Tests and Results
103/4	Correspondence
103/5	Correspondence
103/6	Correspondence
103/7	NTA/MTA Abstracts, Other
103/8	Correspondence, Reports, Contract No. NIH-NIAID 73-2513-P3
103/9	Munich - Borstel Correspondence, Manu's	1965
103/10	Mss. Correspondence
103/11	Helen File, Correspondence, Memos
103/12	Hans Ribi, Cell Wall Skeletons, TDM, MPL, (Tir-Mix 2,3)
103/13	TNI
103/14	Personal Notes
103/15	Monthly Progress Reports other than E.R., Prod. Devel
103/16	Developments in Immunization Agents in Mal. and Infectious Disease
104/17	NIAID Highlights of the Week
103/18	Friday Sessions R and R
103/19	Ribi Incorporated, Reprints
103/20	Lab Planning
104/1	Miscellaneous Papers/Notess
104/2	The Mycobacterial Source Book
104/3	Mycrobacterial Cell Wall Fraction Immunostimulant	1984
104/4	Use of Press. Cell for prep of CW's of Mycobacteria
104/5	Nitrogen
104/6	Nitrogen
104/7	Pasteurella Pestis	1958
104/8	Studies-Fine Structure of Penicillium Chrysogenum
104/9	Phosphorus
104/10	Phosphorus
104/11	Pollen Fractionation	1957
104/12	Prostaglandins
104/13	739 and up Protodyne Notes
105/1	Notes to PP to Conicals
105/2	P3 Isolation
105/2a	P3, B4	1981
105/3	Pyrogen Tests
105/4	Q-Fever Project
105/5	New Method for Purification of Q-Fever/Rickettesia
105/6	Experiment Results
105/7	Experiment Results
105/8	Experiment Results
105/9	Experiment Results
105/10	Experiment Results
105/11	Experiment Results
105/12	Experiment Results
105/13	Bacterial Ribosomes
105/14	Studies- Antigens on Salmonella
106/1	Physical and Chemical Anal. of EXT of Salmonella Enterit
106/2	Sep. and Immunization Sign of Antigens From Salmonella, SAB	1956
106/3	Antigens of Sal. I., Immunization Props. Protoplasm v. CW's
106/4	Steroids
106/5	Steroids
106/6	Steroids
106/7	Sterility and Toxicity Tests, F.D.A
106/8	Toxicity Data Sheets	1956-1958
106/9	Toxicity Data Sheets	1959-1960
106/10	Toxicity Data Sheets	1961, 1962
106/11	Toxicity Data Sheets	1963, 1964, 1965
106/12	Tables
107/1	Trehalose Dimycolate Research
107/2	Experiment Mycobat Morph.- B.Tularense, Growth Cycle IV, Liquid Media
107/3	Effective Non-Living Vaccine Preparations of M.S
107/4	Tumor Experiment
107/5	Tumor Experiment
107/6	Vaccine Experiment Results
107/7	Physics of Viruses
107/8	X-Ray Diffraction Lecture Course

Series IV: Speeches and Writings:, 1954-1986Return to Top

13.0 linear feet

This series contains a mixture of draft and published materials for which Edgar Ribi was either a primary of contributing author regarding issues of immunology and infectious disease research. Materials in this series primarily date from the years of Ribi's work for the National Institutes of Health and include articles, symposium display text, scientific panel presentations, and speeches.

Container(s)	Description	Dates
Box/Folder
108/1	Abstracts	undated
108/2	Titrating Endotoxic Activity on Rabbits	undated
108/3	New Immunization Clin. Apps., Monophos.Lipid "A" Detox ENX	undated
108/4	Immunization of Rab. with CW's from BCG against Tuberculosis	undated
108/5	Progress Report, Pers. Evaluation of Centirchrome	undated
108/6	Purification of Q-Fever, Rickettesiae	undated
108/7	Short Syncrytization of Adjuvant Dipeptide (MDP)	undated
108/8	Antigens in T.A. Hemaggl. in Myco. Tuberculosis	undated
108/9	Anti-Myco Immunization in Rhesus with BCG/Aeresol with M.Tuberculosis	undated
108/10	ACS Meeting Atlanta, Ga	undated
108/11	Act. Guinea Pig Macro by CW's of M. Bovis BCG	undated
108/12	Act. Guinea Pig Macro by Q-Fever Rickettesiae	undated
108/13	Activity of Tre.Dim. from M. Species with M. Dipeptide	undated
108/14	Administration BCG-Cell Wall Skeletons into Mal.Effus.,ToxicandTherapy Effects	undated
108/15	Advisory Council Meeting	undated
108/16	Aerogenic V. with BCG against Tuberculosis In Monkeys - Mulatta	undated
108/17	Aero induced Tuberculosis in Monkeys after I.V. BCG Vaccination	undated
108/18	All Encephalomyelitis Studies for Symposium Presentation	undated
108/19	Alteration of Physical Chemical Biological Properties of ENX with Alkali	undated
108/20	Experiment Model for Immunizationof Cancer	undated
108/21	Non-living Vaccine against Exp Tuberculosis in Mice	undated
108/22	Annual Meet of A.S.C.R., Washington, D.C.	1981
108/23	Antigen Reactive Properties of Fract. of Coxiella Burnetii	undated
108/24	Antigens from CW of S. Enteritidis, Separation, Activity	undated
109/1	Antigens from CW's of Sal. Typhosa	undated
109/2	Antigens of Yeast of Histo Caps., I, Morpho. by Electron Microscope	undated
109/3	Antigens of Yeast of Histo Caps., II, Immunization Properties of PP v CW	undated
109/4	Antigens of B. Pertusis, Activty of CW, PP	undated
109/5	AntiTumor of Detoxed ENT	undated
109/6	App. of Cen. Chrom. in Arthopod Hemolymph, Tissue,etc.	undated
109/7	1st ASM Conference on Biotech. Abs., Ribi	1986
109/8	ASM	1962
109/9	ASM	1963
109/10	ASM Audience List	1963
109/11	ASM	1964
109/12	ASM	1965
109/13	ASM	1971
109/14	ASM	1972
109/15	ASM	1974
109/16	ASM	1975
109/17	BCG-CW Immunization of Intramus/Metast. M.Rat Heptomas	undated
109/18	Bacteria ENT: v.3 Chap. 1	undated
109/19	Bacteria ENT Scavenger-Reception on Human Mono-Macrophages	undated
109/20	Effect of Bacteria ENT on Human Adenovirus	undated
109/21	Mikroorgan. die Immunizationdes Krebses	undated
109/22	Benefitial Modification of ENT Molecule	undated
109/23	BCG CW Components in T Supp. and Regression	undated
109/24	BCG Cell Wall Skeletons, P3, MDP, and Micro. Comp./Structure in Animals	undated
110/1	Berlin	undated
110/2	Bibliography	undated
110/3	Big Sky U.S.-Japan	1975
110/4	Biological/Chemical Characteristics of this Batch ENT in Shock Tour	undated
110/5	Mycobact. (M) CW's, Isolation/Comp.-Cell Wall Skeletons, P3	undated
110/6	M CW's, II Supp./Regr. S.2 Heptoma	undated
110/7	M CW's, III Experiment Enceph. in Guinea Pig	undated
110/8	M CW's, IV Prot. Mice of Myco. Tuberculosis	undated
110/9	M CW's, V Granular Formation in Mice and Guinea Pig	undated
110/10	Pt.1, Mycobat CW's v. Granular Formation in Mice and Guinea Pig	undated
110/11	Pt 2, Mycobat CW's v. Granular Formation in Mice and Guinea Pig	undated
110/12	VI BCG CW in Saline with BCG Oil Vaccine	undated
110/13	Monophosphoryl Lipid "A"	undated
110/14	P. ENT and Lipid Fract. W/Acid-Hyd. ENT	undated
110/15	Biophysical Society, Prog. and Abs.	1959
110/16	BioTech. Development in Bacteria Vaccine Production Conference	1965
111/1	Borstel Colloquium, May	1963
111/2	B4, ACP, Fract., Abs. for 16th Annual Tuberculosis Conference	undated
111/3	Cancer Immunization with Non-living Mycobacts. Comps.	undated
111/4	Cell RandR Inves. W/Sorvall RF-1, Ribi Ref. Cell Fract.	undated
111/5	CW's BCG as Vaccines for Myco. Legrae in Mice (32729)	undated
111/6	Centrifugal Chromotography	undated
111/7	Centrifugal Chromotography of Cannab. Through Microparticulate Silica	undated
111/8	Centrifugal Chromotography of Myco. Lipids	undated
111/9	Centrifugal Chromotography of Micropart. Bed Chromo. of Lipids	undated
111/10	Comparisions of ENT's of Enterobacteriacena	undated
111/11	Investigation on Fract. from Aqueous Ragweed Pollen	undated
111/12	Props of Proteus L. Forms and Parent Forms	undated
111/13	Props of Bacteria L. and Parent Forms	undated
111/14	ENT, I, Prep of ENT with Minimal Lipid Content	undated
111/15	ENT, II, Lipodal Fract. v. Parent ENT	undated
111/16	ENT, III, Kinetic Study of Acid Hydrolosis of ENT	undated
111/17	M CW's, Immunizationto Airborne M. Tuberculosis H37RV	undated
111/18	Chemically Defined Adjuvants of Bacterial Origin	undated
112/1	Chemistry Panel, Institute Pastuer	1963
112/2	Chemotaxogenic and Tumor Regression Glycol, Mclaughlin	undated
112/3	Centri-Chromo of Microbial Lipids in Micropart. Gel	undated
112/4	Centri-Chromo of Mycobacterial Lipids in M. Gel	undated
112/5	Centri-Chromo of Steroids in M. Gel	undated
112/6	Centri-Chromo Separation of Myco. Lipids	undated
112/7	Centri-Chromo Separation of Steroids in Col.'s of Microp. Silica	undated
112/8	Clinical Immunization Newsletter	undated
112/9	1 Committee on Ragweed Pollen Antigens	1963
112/10	2 Committee on Ragweed Pollen Antigens	1963
112/11	Comp. of Myco., Induct of Cell Mediated Immunizationin Mice	undated
112/12	Conference on ENT in Immunization Freiburg 1959, Ribi Self Portrait	undated
112/13	Conference on ENT, Bryn Mawr	1961
112/14	Conference on ENT, Fla.	1963
112/15	Conference on ENT, Pt.1, Houston	1977
113/1	Conference on ENT, Pt.2, Houston	1977
113/2	Conv. of Antigens of C. Burnetti to Hapten by Phenol	undated
113/3	Microbial Agents and Their Biological Properties	undated
113/4	Cross Reactive AGN, Houston	1977
113/5	Current Tuberculosis Research	undated
113/6	Cutaneous Gran. Resp. to BCG CW's in Cancer Immunization	undated
113/7	Delayed Hypersensitivity to Protein in M. Glycolipid	undated
113/8	Skin Reaction in Guinea Pig byMycobat Tuberculosis, etc. Group II Fast Acids	undated
113/9	Determination of Heptose in ENT	undated
113/10	Determination of Impuritites in TDM by Liav/Ribi	undated
113/11	Chromotography Developement	undated
113/12	Dif. Req. for ENT Glycolipid for T Regression ENT Activity	undated
113/13	Disruption/Isolation of Bacteria/Antigens for Anti-Tuberculosis Vaccine	undated
113/14	Disruption of Bacteria and Preparation of CW's	undated
113/15	Disruption of Bacteria and Isolation of AGN	undated
113/16	Doc's-US Delegation Meeting, Pgs. 0-61	1975
113/17	Doc's-US Delegation Meeting, Pgs. 62-123	1975
113/18	Protocol for Experiment I at NCPB, University of California at Davis	undated
113/19	Duration of Immunization to Tuberculosis in Mice with Myco.Bovis BCG	undated
113/20	Early Phase ENT Tolerance: by DTX Lipid "A", Monophos. A	undated
113/21	Ribi, Manuscripts	1954-1958
113/22	ACTH-Rabbit Adrenal, Cytochrome P450, Protein Elec-phos	undated
113/23	BCG CW's on Meta. Potential of Trans. Morris Heptoma	undated
113/24	Monophosphoryl Lipid"A" on Host Resistance to Bacteria	undated
113/25	S. EDS ENT-Lipid"A" on Dermal Reactivity to Epinephr.	undated
113/26	Syn. and Nat. Trehalose, Fatty Acid Esters in T Regress.	undated
114/1	BCG, Myco. and MDP on Resistance to Aero. Influ. Virus	undated
114/2	Nontox Lipid "A" and ENT on Resist to Toxoplasma Gondii	undated
114/3	Pretreat Mice with BCG in Saline on Subsequent Vaccine	undated
114/5	Nonliving Vaccine v. Experiment Tuberculosis in Mice	undated
114/6	M. Bovis BCG v. Pulmonary Inf. of Mycobat Tuberculosis H37RV	undated
114/7	BCG CW-Syn. Hydrocarbon v. Experiment Tuberculosis in Mice	undated
114/8	Various Mycobat CW's v. Tb in Mice	undated
114/9	M CW's BCG v. Airborne Tuberculosis in Subhuman Primates	undated
114/10	T Cell Extracts in Immunoth. of Murine EL-4 Luekemia	undated
114/11	Experiment Tuberculosis in Mice (Swiss)	undated
114/12	Electron Miocroscope (Swiss)	undated
114/13	Electron Microscope, X-Ray Studies on Superpolyamidfaden (Swiss)	undated
114/14	Electron Microscope CW Organization of Plants	undated
114/15	Electron Microscope CW Organization of Wood	undated
114/16	Electron Microscope Morph. of B. Tularense in Liquid Media	undated
114/17	Electron Microscope Morph. of Bacteria, Relation to Immunizationof Experiment Infection	undated
114/18	Electron Microscope of B. Tularense and in vitro/vivo Immunization Reactions	undated
114/19	Electron Microscope CW's of B. Tularense and Relation to Immunization Functions	undated
114/20	Employees List, Phone No.'s	undated
114/21	ENT and Antigens Fract. from CW S. EDS, Bio. Activity	undated
114/22	ENT Extracts in Immunizationof Guinea Pig Line 10 T	undated
114/23	ENT: Perspective of Structure	undated
114/24	ENT Aspects in Relation to Biological Activity	undated
114/25	ENT Receptors in Heptocellular Carcinomas, Mclaughlin	undated
114/26	ENT Seminars, Bethesda	1961
114/27	Enhancement of Anti T Resistance, Ribi et. al.	undated
115/1	Enhancement of Anti T Resistance by Myco. Prods. and ENT	undated
115/2	Enhancement of Chemiluminescence and Phagocytic Activity by Lipid A	undated
115/3	Enhancement of ENT Shock by MDP	undated
115/4	Enhancement of ENT Shock by Diff. MDP Composition	undated
115/5	Enhancement of Immunization Response by Syn Activity of Nontox Lipid A, Mycobat CW	undated
115/6	Enhancement of Macro. Mediated T Cell Killing by Bact. Mem. Prot.	undated
115/7	Enhancement of T Activity by Bacteria Adjuvants	undated
115/8	Enhancement to Resist Tuberculosis by Purified Myco. Lipid Fract.	undated
115/9	Enhancement of T Immunizationby Monophosphoryl Lipid "A"	undated
115/10	Enzymes from E. Coli by Sorvall Cell Fractionator	undated
115/11	Eradication by Myco. Vaccine and T Cell of Micro Metas's	undated
115/12	Erad. Lymph Node Matas. after Injection of ENT/Myco Comps.	undated
115/13	Extract/Purification of ENT from Enterobact., Comparisons	undated
115/14	Factors Prot. Against Experiment Tuberculosis by Heat Stable CW Vaccine	undated
115/15	FASB Atlantic City	1972
115/16	Electron Microscope, X-Ray Difract. of Histo. Capsulatim	undated
115/17	Footpad Sensitivity/Resist by Vaccine of Myco. CW	undated
115/18	Fract. of M. bovis BCG	undated
115/19	Fract. of Mycobact.	undated
115/20	Centri-Chromo Fract. of Wax "D" in Micro Parts	undated
115/21	Occurance of Nat. Haptenin Enterbacteriological Sp.	undated
115/22	Structure Recs. for Agent of IMM. in Guinea Pig Line 10 T	undated
115/23	Glucan: 5 Syngeneic Tumors in Guinea Pig and Mice	undated
115/24	Harnessing the Beneficial Effects of ENT	undated
115/25	Harvesting and Disintegration	undated
115/26	Hexoamines, Notes, Cancers	undated
116/1	Host Reative Props. of Myco, Comps. in Anti T Immunization	undated
116/2	Hybird Formation Between Bacterial ENT	undated
116/3	Immunization Prophlaxis of Myco. Infections	undated
116/4	Immunization Responses in R. Monkeys with BCG, Aerosol-M Tuberculosis	undated
116/5	Immunization of Mice Vaccinated with BCG CW's	undated
116/6	Immunization of Rabbits with Viable BCG and CW Vaccine	undated
116/7	Immunization of Mice by Inactive Fract. of M. Bovis BCG	undated
116/8	Immbio. Activity of Nontoxic Lipid "A"	undated
116/9	Immunization of Mycobat CW Experiment to Airborne Tuberculosis in Mice (Swiss)	undated
116/10	Immunization of CW from Myco.s to Airborne Tuberculosis in Mice	undated
116/11	Immunization of CW from M. Lepraemurium to Airborne Tuberculosis	undated
116/12	Immunization Approaches to Human Cancer by Guinea Pig Model	undated
116/13	Immunization Prop. of Proto v. CW, New Isolation of ENT	undated
116/14	Immunization Signifigance of CW of Mycobacteria	undated
116/15	Immunization Props. of CW v. Proto. from Mycobacteria	undated
116/16	Immunization Role of Brucella Abortus CW's	undated
116/17	Immunization Potentiating Activity of Monophosphoryl Lipid "A"	undated
116/18	Immunization BCG With Myco. Fract. in Lung Cancer (Swiss)	undated
116/19	Immunization for T with Microbial Contents or Syn. Analogues	undated
116/20	Immunization of Guinea Pig Heptoma with living BCG	undated
116/21	Immunization of Bovine Neoplasms with Cell Wall Skeletons, TDM, MPL, CY	undated
116/22	Immunization of Bovine Squamous Carcinoma with Cell Wall Skeletons, TDM	undated
116/23	Immunization of Cancer Regss. of Intrad. T in Intral. Inj. MCW	undated
116/24	Immunization of Cancer T Supr./Rgrss.by CW of Mycobat Phlei in Oil	undated
116/25	Immunization of Equine Sarcoid with Cell Wall Skeletons TDM Biologic	undated
116/26	Immunization of Occ. Squam. Cell Carci. in Cattle with Myco.B.	undated
116/27	Immunization of Antigen Intramus.T and Pulmon. Metas. by BCG CW	undated
116/28	Immunization of Nonviable Micro. Comps.	undated
116/29	Inactivity of ENT with Bile Salt, Human Plasma Comp.	undated
116/30	Induction of Resistance to Tuberculosis in Mice with Myco., unrelated	undated
117/1	Inf. Dis. Soc. of Am. Presented at 8th Ann.	1970
117/2	Fine Lipid "A" on Limulus Amebocyte Lysate, and Toxics	undated
117/3	Fine Lipid "A" to its Limulus A.L. Clots, and T Rgrss.	undated
117/4	Inhib. Pul. Gran. by Myco. Proto and Immsup. to Mycobat Tuberculosis	undated
117/5	Int. Conference of Immun, Pharmacy (2d), Wash. D.C.	1982
117/6	Int. Symposium, on Immu. of Cancer, Prog. Abs, etc.	1985
117/7	Intrales Immunization of M. Melanoma by M. Smegmatis Cell Wall Skeletons TDP3	undated
117/9	Intra T Chemical Immunization by MitocinC and Mycobat in Rgrss.of Line 10 T	undated
117/10	Phaze I, II of Intra T Immunization with BCG Cell Wall Skeletons plus P3	undated
118/1	Isolation and Composition of P3	undated
118/2	Isolation of Nontox Lipid "A" Fract. with T Rgrss. Activity	undated
118/3	Isolation Immunization Toxic Comps from Cord Factor Mycobat Tuberculosis Auyama B	undated
118/4	Isolation of Biol. Act. Comps of Myco. CW, Strain 2 Guinea Pig Hept.	undated
118/5	KDO, never published	undated
118/6	Landy Invite List Program, etc.	1965
118/7	Lipid "A" and Immunotherapy	undated
118/8	Localand Systematic Immunization of Human Cancer byMycobat Cell Wall Skeletons, TDP3	undated
118/9	MAAF, Notes R.S., N.S.	undated
118/10	Malginant Effusions Phase I, II Richman	1979
118/11	Migrat. Inhibit. Study of M. Bovis BCG, Relationships	undated
118/12	Manuscript, Electron Microscope Morph. of B. Tularense, during Growth in Liquid	undated
118/13	Manuscript, Electron Microscope, X-Ray on Superpolymide Fibers	undated
118/14	Manuscript, Fine Structure of Cellulose Experiment	1950
118/15	Manuscript, Fine Structure of Rayon, Arkev fur Kemi	1950
118/16	Manuscript, - --,---, Activity of ENT, 3Mss-2Mss	undated
118/17	Manuscript, Submicro. Structure of Fibers and Formation	1981
118/18	Manuscript, Electron Microscope Struct of B. Tularense, in vitro/vivos in Immunization	undated
118/19	Manuscript, Disruption of Bacteria, Stockholm Conference	undated
118/20	Manuscript, Bacteria AGN, Disc.of Bacteria prep of CW, GalliProof	undated
118/21	Manuscript, Factors Infl. Protection Against Experiment Tuberculosis	undated
119/1	Manuscript, Reaction of ENT and Surfacants	1966
119/2	Marijuana: ID of Cannab. by CC	undated
119/3	Measure of Antibact. Immunization Stim.dby O ANG, S. Typhosa	undated
119/4	Mech/Struct Req of BCG CW for Syn.T Rgrsswith ENT Gly	undated
119/5	FASEB Meeting, Chicago	1983
119/6	FASEB Meeting, Atlantic City	1972
119/7	Mt. Tuberculosis Assn. Helena	1968
119/8	Seminar in GTF	1973
119/9	Meeting of US Delegation	1976
119/10	Meeting of US Delegation	1976
119/11	12th Meeting of US-Japan Cooperation Medical Science Committee	1976
119/12	12th Meeting of US-Japan Cooperation Medical Science Committee	1976
119/13	Meeting US-Japan	1971
119/14	Meeting US-Japan	1973
119/15	Meeting US-Japan	1972
120/1	Meeting 2nd Annual Conference Carcinogen Progress	1973
120/2	Micropart. Bed Chromo. Accel.d by Centrifuge	undated
120/3	Annual Meeting Infectious Disease Soc.	1970
120/4	Micropart. Gel Chromo. Accel. by Centrifuge	undated
120/5	Migrat. Inhibit., and Type II Interferon in Mycobact.	undated
120/6	Structure Req. of Microb. Agents as Immunization Potential for Tuberculosis,T	undated
120/7	Mss. Papers No Titles	undated
120/8	Miscellaneous	undated
120/9	Miscellaneous	undated
120/10	Miscellaneous on Endotoxins (ENT)	undated
120/11	Miscellaneous Notes, Fract. v. Hypothesis, Purpose	undated
120/12	Miscellaneous Notes	undated
120/13	Mod. of Host React. Prop of ENT by Sodium Deoxcholate	undated
120/14	Mod of Humoral/Cell Mediated Immunization Resp.by Nontox Lip.A	undated
120/15	Moieties of Mycobact. Mycolates to Induce Gran. React.	undated
120/16	Molecular concepts of Lipid "A"	undated
120/17	Monophos. Lipid"A" from Lipopolysacc. of S. Minne. R595	undated
120/18	Montreal Symposium	1976
120/19	Morph. of B. Tularense During Growth in Liquid byElectron Microscope	undated
120/20	Myco. Cellular Antigens Fract.	undated
120/21	Myco. CW Comp. in T Supr./Rgrss.	undated
120/22	Myco. Comp.s in Cancer Immunotherapy	undated
120/23	Myco. Comp.s Resp. for Gran. Inflammations	undated
120/24	Mycolic Acid of M.Rhodochrous, Nocardia Corallina	undated
120/25	NIH Lecture	1962
121/1	Nonclinical Study of Magreg Vaccine	undated
121/2	Nonspec.Immstim.for aero.Inf.Tuberculosis/Flu by Syn. MDP, TDP3	undated
121/3	N.Y. Academy of Science	1956
121/4	Occult ENT in Bacteria Protplasm	undated
121/5	ENT: Struct/Immunization of Host Resp.	undated
121/6	Others	undated
121/7	Others Cantrell Publications	undated
121/8	Others Cantrell Publications	undated
121/9	Others	undated
122/1	Others	undated
122/2	Others	undated
122/3	Others: The Piel Chromosomes Techniques	undated
122/4	Out line of Q-Fever Studies	undated
122/5	Orig/Prop of Naturally Occuring Hapten from E.Coli	undated
122/6	Overview of Membrane Filters	undated
122/7	Panel Discussions	1963
122/8	500 27 Paper II, Draft, Tables	undated
122/9	Part Purif. of Imm Material in Lipid Ext. of Mycobact.	undated
122/10	Parvum Paper	undated
122/11	Pas.Trans. of T by Spleen Cell from Cured Guinea Pig	undated
122/12	Peptide Req. Imm of Guinea Pig Line 10 T with ENT	undated
122/13	Phase I, II, Intra T Immunization by BCG Cell Wall Skeletons, P3	undated
122/14	Phase I, by Intra T, Intracavitary BCG Cell Wall Skeletons, P3	undated
122/15	Phase I, Intradermal Immunization by Oil-M. Smegatis Cell Wall Skeletons, TD	undated
122/16	Phys/Chem Changes in ENT Ass'd with Loss of Bio. Potent	undated
123/1	Physical/Chem Anal. of ENT from S. Enteritidis	undated
123/2	Physical of Reverse Inacttivation of ENT	undated
123/3	Phys ofAntigens Nat. Protopl. Polysacc. from E.Coli	undated
123/4	Physical Structure of Native Hapten	undated
123/5	Plasma-Depend Chemotaxis of Macrop.to BCG Cell Wall Skeletons, Mycobat GlyP3	undated
123/6	Preparation and Anti T Activity of Nontoxic Lipid "A"	undated
123/7	Prep/Host Reactive Propof ENT with Low N, and Lipid	undated
123/8	PreparationHostProp ofAl CitrateENT Complex of S. Enteri	undated
123/9	Preparation of CW/Protop. of Neisscria by Ribi Cell Fract.	undated
123/10	Prep of Microorg.s for Electron Microscope	undated
123/11	Prep of Adjuvant-Act Tuberculosisn Free Peptidogly. of Human Tuberculosis	undated
123/12	Prep, Prui. and Structure of ENT	undated
123/13	Preparationof 209: New Type "Bio. Resp. Modifier"	undated
123/14	Persentation in Berlin Germany	undated
123/15	Pres. Accel.Chromo by Micropart. Silica Columns	undated
123/16	Prevent of Pul. Gran. by AGN/Agents to Aero.Mycobat Tuberculosis	undated
123/17	Procedure for prep of Antigens by M. ParaTuberculosis	undated
123/18	Production Model Press for Progress Reportsep. of Bacteria Cell Walls	undated
123/19	Progress in the Search for a Tuberculosis Vaccine	undated
123/20	Prot. of Monkeys to AirborneTuberculosis by Aero Vacc of BCW's	undated
123/21	Prot. Effect of MDP with TDM to Aero Influ. Virus	undated
123/22	Purdue Lecture	1959
123/23	Purified THC, by Accel.d Micropart. Gel Chromo.	undated
124/1	Purification of THC, Tables and Graphs	undated
124/2	Nonliving Lipid Antigens from Lipposacc. of S.Typhimurium	undated
124/3	Puri. Synthetic THC Centri-Chromo in 8mm columns	undated
124/4	Purification of Q-Fever Rickettsiae by Density Gradient	undated
124/5	Reaction of ENT and Surfacants (I)	undated
124/6	(II) Immunization Props of ENT by Sodium Deoxycholate	undated
124/7	React. E. Coli ENT to Lithium Al Hydride	undated
124/8	React. of Papain Treated ENT	undated
124/9	Rgss. of Est. T's from ENT and Myco Fract.	undated
124/10	Rgss. of Line 10 Heptocel. Carc. by Micro Ext. Mycolates
124/11	Rgss. of T by ENT with Trehalose Myco. of Dif. Structure	undated
124/12	Rgss. of T by ENT and Myco Fract.	undated
124/13	Rgss. of T Induced Adju. Active Bacteria Comp.and Syn's	undated
124/14	Fine Lipid Antigens to Limulus Ameb. Lys.,Toxic, T Rgss. Activity	undated
124/15	Structure and Host React. Prop. of Microorganisms	undated
124/16	Chemical Comp to Biological Activity	undated
124/17	Physical Chem Change in ENT Lose of Potent by Acid Hydrol.	undated
124/18	Relat. Footpad to PPD Resistance Inf. Mycobat Tuberculosis in Mice Mycobat CW's	undated
124/19	Relate. Structure of Microorganisms to Host React. Props.	undated
124/20	Reprod of - ----, Antigens 352, S. Bedford B.H. CA 90212	undated
124/21	Resistance to Experiment Tuberculosis by Fract. Attn.d Tubercule Bacilli	undated
124/22	Resistance to Tuberculosis in Mice Immunizationd by BCG Disr.d in Oil	undated
125/1	Req. of Different Chemical Structure of ENT Gly. for T Rgss. Activity	undated
125/2	Immunization Chem Research Pub.s	undated
125/3	RIR-Mondino, ABS, 1981 CW-S S. Auveus	undated
125/4	Morph. Ele.s of Microorgs in Immunization/Phenomena	undated
125/5	Role of Mycobact. in Immunization of Cancer	undated
125/6	Rutger Symposium, Papers	1961
125/7	Rutger Symposium, Papers	1961
125/8	Rutger Symposium, Papers	1961
125/9	Rutger Symposium, Papers	1963
125/10	Science Writers Seminar (SElectron Microscope), Mar.	1964
125/11	Sci. Writers SElectron Microscope. 1986 Memo	undated
125/12	SElectron Microscope Fract. of B. Tularense Myco., Salmonella Spp., Histoplasm	undated
125/13	Sep./Chara. of Toxic/NonToxic Lipid A	undated
125/14	Sep./Imm Sign. of Antigens from Salmonella	undated
125/15	Sep. of ENT from Heptoseless Mutant of S.Typhimurium	undated
125/16	Sep. of Sugars by Centri-Chromo Micropart. Bed	undated
125/17	Sep. Trehalose 6,6 Dimycolates in Myco.Gly. Fract. P3	undated
125/18	Sep. Mycolic Acid Esters from Mycobact.	undated
125/19	Simple Preparation of Puri. Radioactive Polio Parts by Electron Microscope	undated
125/20	Site of Itracel. Antigens in 3 Non-Influ. myxovirus, Fluores.	undated
125/21	Skin React. by Typ/Nontyp. Myco. with Homo/Hetro Prot.	undated
125/22	Skin React. by CW and Proto. of Mycobat Tuberculosis, Mycobat Butricum	undated
125/23	Solub. of ENT, Stabil. of Biol. Activity in Organic Liq.	undated
125/24	Some Currents in Tuberculosis Research	undated
125/25	Phys/Chem/Biol of Antigens Liberated from S. Enter./S Typh.	undated
125/26	Spec/Nonspec. Stim. of Resist to Tuberculosis in Mice	undated
126/1	Spec/Nonspec. Stim of Resistance in Mice with Mycobat Tuberculosis H37RV	undated
126/2	Spec to Resistance Tuberculosis and Salmonellis by Oil-Treated CW's	undated
126/3	Stim. of Chemiluminescence by Nontox/Tox Lipid A	undated
126/4	Literature on CW's of Mycobact., Japan	undated
126/5	Delayed Reaction by Proto. of Acid-Fast Bacilli as AGN	undated
126/6	Proto of Acid-fast Bacilli Provoking Delay React in Guinea Pig	undated
126/7	Relate. Chemical Comp. and Biol. Prop. of ENT	undated
126/8	I) Biol.Prop. of Firm Bound Lipid v. Parent ENT	undated
126/9	II) Kinetic Study of Acid Hydolisis of ENT	undated
126/10	Study Prog. in Biophysical Sci., Boulder	1958
126/11	Strain, et al., Mss. Preps	undated
126/12	Structure/Biol Activity of ENT	undated
126/13	Structure/Biol Func. of Mycobact.	undated
126/14	Structure Req.s of Microbact. Agents, Montreal Symposium, Ms	undated
126/15	Structure Req.s Microb. Agents for Immthpy. of Guinea Pig Line 10 T	undated
126/16	Structure/Biological Function of Mycobacteria	undated
126/17	Structure/Biological Function of Mycobacteria, Annual New York Academy of Science	undated
127/1	Struct/Func of Bacteria Adjuvants	undated
127/2	Struct/Func Relate. of Myco. Comp/Detox.d Ext.Re Mutant	undated
127/4	Struct/Func Relate. of LipidAntigens to Enhance Anti T Activity	undated
127/5	Structured Ele. of Hist. Caps., Role in Immunization to Experiment Dis.	undated
127/6	Struct Moieties of MycoLipid for Prod.of Gran. React.	undated
127/7	Struct Req. of ENT Gly.for anti T/Toxic Activity	undated
127/8	Struct Req. for Microb. Agents in Imm of Line 10 in Guinea Pig	undated
127/9	Submicro. Structure of Fibres, Formation	undated
127/10	Summ of Prog. on Centri-Chromo of Lipids	undated
127/11	Summ Rpt. on ChemicalComp./Biol.Prop.of ENT of S.Enterit.	undated
127/12	Sup. of Intravein. BCG/BCG-CW in R.Monkey to Airborn Tuberculosis	undated
127/13	Sprss/Rgss Line 10 T Guinea Pig Hept.by MAAF and P3	undated
127/14	Sprss T Growth/Rgrss of Est.T byOil Att.dMyco Fract.	undated
127/15	Symposium, Annual Meeting: Amer. Chemical Soc., Kansas	1982
127/16	Symposium, ASM Meeting, Cleveland	1963
127/17	Symposium, Host Reactive Prop. of CW from Mycobact.	1963
128/1	Symposium, Bactoremic Shock, Manu.,Prep,Puri.Struct	1964
128/2	Symposium, on Bacteria ENT,I) Chemical Comp to Biol Activity	undated
128/3	Symposium, on Biotech. Devel. in Bacteria Vaccine Prod.	undated
128/4	Symposium, on ENT	undated
128/5	Symposium, on ENT Relate. Chemical Comp.to Biol Activity	1963
128/6	Symposium, Struct/Biol Prop. of Surface Antigens of Gm-Neg Bact	undated
128/7	Symposium, on ENT of Comp/Struct Relate to Biol. Activity	undated
128/8	Symposium, of Immunization of Cancer, Japan 9 18-20	1985
128/9	Symposium, Relate Structure of Microorg. to Immunization Props, Hosts	undated
128/10	III) Struct/Biol Prop of Surface Antigens of Gm-Neg Bact	undated
128/11	Symposium, Papers, Presented Stockholm, Paris, Ottawa	1971
128/12	Symposium, Shock Tour	undated
128/13	Syner.Activity of Mycoand Mutant Sal.in Rgss in Line 10 Guinea Pig	undated
128/14	Syner Rgss after Line 10 Cars.by Deprot. BCG-CW, S.Typ	undated
128/15	Syn. and Nat. Trehalose Fatty Acid Esters in T Rgss	undated
128/16	Taxo.Class of Myco through Collaborations Micropart. Gel C	undated
128/17	Thesis	undated
128/18	TLC, Literature Notes, Chloreserol Esters	undated
128/19	Mod. App. of Ribi Products with CY's and BRM's	undated
128/20	Tox. and Antigens Prop of Fract. of Q-Fever Rickettsiae	undated
128/21	Tox/Pyro/Mitogenic Prop of Fract of a RExperiment Mutant ENT	undated
128/22	Treat Melanoma by Low CY Autologus Mel.Detox ENT, BCG	undated
128/23	TDM of Myco.spp, Dif. AntiInf. Activity with MDP	undated
128/24	Trehalose Palmitates in T Rgss, Planned Pub.s	undated
128/25	Tuberculosis	undated
129/1	Tuberculosis Shortened Syn. of Adjuvant MDP	undated
129/2	Tuberculosis Meeting Hamilton MT	1965
129/3	T Rgss with MAAF and P3	undated
129/4	T Rgss Caused by ENT with TDM	undated
129/5	T Rgss Caused by ENT with Myco. TDM	undated
129/6	T Rgss Caused by ENT with Myco. Fract.	undated
129/7	T Rgss by Oil/Water Emulsion Mediated to Oil	undated
129/8	T Rgss Mediated by Bacteria Glycolipids	undated
129/9	T Rgss Mediated by Comp.s of Myco.	undated
129/10	T Rgss by Nontoxic Microbial Comp.s	undated
129/11	T Rgss of Q-Fever Rickettsiae and Myco. Glycolipid	undated
129/12	T Spss by Cw of M. Bovis on Oil Droplets	undated
129/13	Uber den Feinbau der Viscosseide	undated
129/14	Uber den Feinbau der Cellulose	undated
129/15	Uber Hydroxyuerbindungen des Mangans	undated
129/16	Ultrastruct. of Exosporium enveloping spores Bac.Cereus	undated
129/17	ENT in Cancer Imm and Chara. of Nontox. Lipid Comps	undated
129/18	Use of Pres. Cell to Preparation CW from Myco.	undated
129/19	9th Joint Tuberculosis Conference Kyoto, Japan	undated
129/20	10th US-Japan Tuberculosis Res. Conference, Big Sky, Montana	1975
129/21	US-Japan 5 year Report	1970-1975
129/22	US-Japan Coop. Medical Science Program	undated
129/23	US-Japan Coop. Medical Science Program	1977
129/24	US Tuberculosis Panel	undated
129/25	US-Japan Tuberculosis Conference San Fransico, CA	1971
129/26	X-Ray Anal. of Swelling Woodpulp by Sodium Hydroixde	undated
129/27	Zur Derzeitigen Exp und Klinischen Unspec. Imm Krebses	undated
129/28	Zur Electron Microscope Preparation von Kolloiden	undated

Series V: Ribi ImmunoChem, 1981-1986Return to Top

4.0 linear feet

The materials in this series document the efforts of Edgar Ribi and his associates to organize, incorporate, secure investors, and manage Ribi ImmunoChem, a private company focused on developing anti-cancer agents, anti-infectious agents, and super vaccines. Company records include Board of Directors records and correspondence, internal memos, legal documents (particularly patent and liability declarations), publicity materials, product development documentation, Ribi's personal notes, and financial records.

Container(s)	Description	Dates
	Subseries 1: Company 3.0 linear feet	1981-1986
Box/Folder
130/1	Board of Directors, General	1984-1986
130/2	Board of Directors Meeting	April 1985
130/3	Board of Directors Meeting	June 1985
130/4	Board of Directors Meeting	September 1985
130/5	Board of Directors Meeting	December 1985
130/6	Board of Directors Meeting	April 1986
130/7	Board of Directors Meeting	June 1986
130/8	Intracompany Memos	1985
131/1	Intracompany Memos	1985
131/2	Intracompany Memos	1985
131/3	Intracompany Memos	1985
131/4	Intracompany Memos	1986
131/5	Intracompany Memos	1986
131/6	Legal Document, Employment Agreement	1985
131/7	Legal Document, Bond Issue	1981
131/8	Publicity and Clippings	1982-1986
132/1	Product Development, General Correspondence and Notes	1982-1984
132/2	Product Development, General Correspondence and Notes	1983-1984
132/3	Product Development, Presentation, March	1984
132/4	Product Development, Presentation to Johnson and Johnson	June 1984
132/5	Product Development, Animal Vaccine Adjuvant/Human Vaccine Adjuvant and RibiGen	1985
132/6	Product Development, Brucella Vaccine and RibiGen Adjuvant Scale-Up	1985
133/1	Product Development, Detox, Ovamid and Polymerized Liposomal Adjuvants	1985
133/2	Product Development, Paratuberculosis and Bovine Brucellosis Diagnostics	1985-1986
133/3	Product Development, Ovamid, Detox, RibiGen Adjuvant Scale-Up and Adjuvant Research	1985-1986
133/4	Product Development, Bovine Brucellosis Diagnostic and Brucella Vaccine	1986
133/5	Product Development, Triple Mixture, Animal Vaccine Adjuvant, Human Cancer Preclinical, Human Vaccine Adjuvant, NSR/Endotoxemia/Immuno-deficiency	1986
134/1	General Notes and Articles	1984-1986
134/2	General Notes	1984
134/3	General Notes	1985
134/4	General Notes	1985-1986
	Subseries 2: Financial 1.0 linear feet	1981-1984
Box/Folder
135/1	Statements	1984
135/2	Statements	1984
135/3	Statements	1984
135/4	Statements	1984
135/5	Statements	1983
135/6	Statements	1983
130/7	Statements	1983
135/8	Statements	1982
135/9	Statements	1981
136/1	Product Outlets/Shipments Blackbook	undated
136/2	Prospectus	undated
136/3	S.B.A. Inventory Res. Proposal	1985
136/4	Production Schedule	1981
136/5	BCG CW Distribution Record	undated
136/6	Shares, References	undated
136/7	RibiGen, Regression	undated
136/8	Good Management Practices, Code of Federal Regulations, Food and Drug Administration	undated
136/9	Expanded Business Plan	1985
136/10	Microfluids	undated
136/11	Memos on Invention	undated
136/12	Patents, Legal Challenge	undated
136/13	Public Relations, RibiGen Cell Wall Skeletons-TDM	undated
136/14	Public Relations RibiGen Cell Wall Skeletons-TDM	undated
136/15	Product Capacity, Cost Analysis, P3 and MPL	undated

Series VI: Electron Micrographs, undatedReturn to Top

5.5 linear feet

This series consists of 4653 electron micrographs, photographs of specimens taken through an electron microscope. These images were likely created during Ribi's research for the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana.

Container(s)	Description	Dates
Box
137	Reference list to electron micrographs and electron microscope operator's manual	undated
138	Electron micrographs, #4969-5473
139	Electron micrographs, #5474-6239
140	Electron micrographs, #6240-6966
141	Electron micrographs, #6993-7591
142	Electron micrographs, #A1-A100
	Electron micrographs, #B1-B100
	Electron micrographs, #C1-C100
	Electron micrographs, #D1-D100
Box
143	Electron micrographs, #E18-E100
	Electron micrographs, #F1-F100
	Electron micrographs, #G3-G18
	Electron micrographs, #G72-G94
	Electron micrographs, #H19-H100
	Electron micrographs, #I1-#100
	Electron micrographs, #J1-J100
	Electron micrographs, #K1-K100
	Electron micrographs, #L1-L12
Box
144	Electron micrographs, #L13-L100
	Electron micrographs, #M1-M100
	Electron micrographs, #N1-N100
	Electron micrographs, #O1-O100
	Electron micrographs, #P1-P12
Box
145	Electron micrographs, #P13-P100
	Electron micrographs, #Q1-Q100
	Electron micrographs, #R1-R95
	Electron micrographs, #S7-S100
Box
146	Electron micrographs, #T1-T100
	Electron micrographs, #U1-U100
	Electron micrographs, #V1-V57

Series VII: Chromatographs, undatedReturn to Top

0.5 linear feet

This series consists of 470 chromatographs, a technique of separating and analyzing the components of a mixture of liquids or gases by selective adsorption and depicted as a column or strip of material ranges. These chromatographs were likely created during Ribi's research for the National Institute of Allergy and Infectious Diseases Laboratory in Hamilton, Montana.

Container(s)	Description	Dates
Box
147	Chromatographs, #S1-S343
147	Chromatographs, #SV1-SV127

Series VIII: Photographs, 1928-1975Return to Top

9 images

This series contains 9 photographs of Edgar Ribi and the Rocky Mountain Laboratory facilities in Hamilton, Montana. Included are two images of early facilities and one from 1963 that also captures the western portion of the Bitterroot Valley in 1963.

Container(s)		Description	Dates
Box/Folder	photo_number
137/1	197(VIII):1	Edgar Ribi, Lecturing	circa 1975
137/1	197(VIII):2	Edgar Ribi with a group of men, Big Sky, Montana	1975
137/1	197(VIII):3	Doctors Edgar Ribi and Carl L. Larson examining fractions of M. tuberculaturn through an electron microscope	circa 1965
137/1	197(VIII):4	Doctor Ribi, at blackboard, his professional staff, and foreign researchrs during an informal seminar	1965
137/1	197(VIII):5	Technical services at Rocky Mountian Lab, a few stacks in the medical library	1964
137/1	197(VIII):6	Technical services at Rocky Mountian Lab, animal research areas	circa 1964
137/1	197(VIII):7	U.S. Public Health Service Laboratory building, Hamilton, Montana	circa 1920s-1930s
137/1	197(VIII):8	Montana State Board of Entomology building, housed the U.S. Public Health Service Spotted Fever Laboratory, Hamilton, Montana	1928
137/1	197(VIII):9	Rocky Mountain Laboratory complex and west neighborhoods of Hamilton, Montana	1963

Names and SubjectsReturn to Top

Subject Terms

Biochemistry--Research -- Montana--Hamilton
Communicable diseases -- Research--Montana--Hamilton
Immunology--R esearch -- Montana--Hamilton
Oncology--Research -- Montana--Hamilton
Swiss Americans -- Montana

Corporate Names

National Institute of Allergy and Infectious Diseases (U.S.)
National Institutes of Health (U.S.)
National Institutes of Health (U.S.). Rocky Mountain Laboratory

Occupations

Biophysicists--Montana --Hamilton
Businessmen--Montana --Hamilton

Other Creators

Corporate Names
- Ribi ImmunoChem Research, Inc.

Archives West Finding Aid

Table of Contents

Edgar Ribi Papers, 1950-1986

Overview of the Collection

Biographical NoteReturn to Top

Content DescriptionReturn to Top

Use of the CollectionReturn to Top

Restrictions on Use

Preferred Citation

Administrative InformationReturn to Top

Arrangement

Custodial History

Acquisition Information

Processing Note

Detailed Description of the CollectionReturn to Top

Series I: Biographical, 1951-1980Return to Top

Series II: General Correspondence, 1950-1986 Return to Top

Series III: Research Files, 1953-1980Return to Top

Series IV: Speeches and Writings:, 1954-1986Return to Top

Series V: Ribi ImmunoChem, 1981-1986Return to Top

Series VI: Electron Micrographs, undatedReturn to Top

Series VII: Chromatographs, undatedReturn to Top

Series VIII: Photographs, 1928-1975Return to Top

Names and SubjectsReturn to Top

Subject Terms

Corporate Names

Occupations

Other Creators

Corporate Names

Finding aid prepared by Jodi Allison-Bunnell, Jack Rowan, Jennifer Rose, and Jennifer Lodine-Chaffey
2004

Archives West Finding Aid

Table of Contents

Edgar Ribi Papers, 1950-1986

Overview of the Collection

Biographical NoteReturn to Top

Content DescriptionReturn to Top

Use of the CollectionReturn to Top

Restrictions on Use

Preferred Citation

Administrative InformationReturn to Top

Arrangement

Custodial History

Acquisition Information

Processing Note

Detailed Description of the CollectionReturn to Top

Series I: Biographical, 1951-1980Return to Top

Series II: General Correspondence, 1950-1986 Return to Top

Series III: Research Files, 1953-1980Return to Top

Series IV: Speeches and Writings:, 1954-1986Return to Top

Series V: Ribi ImmunoChem, 1981-1986Return to Top

Series VI: Electron Micrographs, undatedReturn to Top

Series VII: Chromatographs, undatedReturn to Top

Series VIII: Photographs, 1928-1975Return to Top

Names and SubjectsReturn to Top

Subject Terms

Corporate Names

Occupations

Other Creators

Corporate Names

Finding aid prepared by Jodi Allison-Bunnell, Jack Rowan, Jennifer Rose, and Jennifer Lodine-Chaffey 2004

Finding aid prepared by Jodi Allison-Bunnell, Jack Rowan, Jennifer Rose, and Jennifer Lodine-Chaffey
2004